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1.The anatomy of heart 
The heart is a muscular pump that serves two functions: (1) collect blood from the tissues of the 
body and pump it in the lungs and (2) collect blood from the lungs and pump it in all tissues of the 
body. The human heart is located in the thorax,protected posterior to the sternum and costal 
cartilages, rests on the superior surface of the diaphragm, assuming an oblique position in the 
thorax, with two-thirds of the left of midline. It occupies a space between the pleural cavities called 
the middle mediastinum, defined as the space inside the pericardium, covering around the heart. 
This serous membrane has a inner and outer layers, with a lubricating fluid in between. The fluid 
allows the inner visceral pericardium to “glide” against the outer parietal pericardium. 
The internal anatomy of the heart reveals four chambers composed of cardiac muscle or 
myocardium. The two upper chambers (or atria) function mainly as collecting chambers; the two 
lower chambers (ventricles) are much stronger with the function to pump blood in system 
circulation. The role of the right atrium and ventricle is to collect blood from the body and pump it 
to the lungs. The role of the left atrium and ventricle is to collect blood from the lungs and pump it 
throughout the body. There is a one-way flow of blood through the heart; this flow is maintained by 
a set of four valves. The atrioventricular valves (tricuspid and bicuspid) allow blood to flow only 
from atria to ventricles. The semilunar valves (pulmonary and semilunar) allow blood to flow from 
the ventricles out of the heart and through the great arteries [1] 
The division of the heart into four chambers produces boundaries that are visible externally as 
grooves (sulci). The interatrial groove is a shallow groove separating the two atria. The lateral limits 
are defined by the borders of the atria. The atrioventricular (coronary) groove (or sulcus) separates 
the atria from the ventricles. This groove, containing the main trunks of the coronary arteries, is 
oblique. It descends to the right on the sternocostal surface, separating the right atrium (and its 
auricle or appendage) from the oblique right margin of the right ventricle and its infundibulum. Its 
upper left part is obliterated where it is crossed by the pulmonary trunk and, behind this, the aorta, 
from which the coronary arteries originate. Continuing to the left, the groove curves around the 
obtuse margin and descends to the right, separating the atrial base from the diaphragmatic surface of 
the ventricles. 
Internally, the ventricles are separated by the septum. The mural margins of the septum correspond 
to the anterior and inferior (diaphragmatic) interventricular grooves. The anterior groove, seen on 
the sternocostal cardiac surface, is near and almost parallel to the left ventricular obtuse margin. On 
the diaphragmatic surface, the groove is closer to the midpoint of the ventricular mass. The 
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interventricular grooves extend from the atrioventricular groove to the apical notch on the acute 
margin, which is a little to the right of the true cardiac apex. 
A cross section cut through the heart reveals three layers: a superficial visceral pericardium or 
epicardium; (2) a middle myocardium; and (3) a deep lining called the “endocardium”. The 
endocardium is a sheet of epithelium called endothelium that rests on a thin layer of connective 
tissuebasement membrane. It lines the heart chambers and makes up the valves of the heart. 
The myocardium is the tissue of the heart wall and the layer that actually contracts. The 
myocardium consists of cardiac muscles willing in a spiral arrangement of myocardium that 
squeezes blood through the heart in the proper directions (inferiorly through the atria and superiorly 
through the ventricles). Unlike all other types of muscle cells, cardiac muscle cells: (1) branch, (2) 
join at complex junctions called intercalated discs so that they form cellular networks, and (3) each 
contain single, centrally located nuclei. A cardiac muscle cell is not called fiber because the term is 
used for a long row of joined cardiac muscle cells [2].     
 
1.1 Cardiac microstructure  
In cardiac muscle, as in skeletal muscle, the contractile proteins are organized structurally into 
sarcomeres which are aligned in register across the fibres, producing fine cross-striations that are 
visible in the light microscope. They both contain the same contractile proteins (although many are 
cardiac isoforms), which are assembled in a similar way, and the molecular basis for contraction, 
but not its regulation, is the same. The release of calcium into the sarcoplasm triggers contraction, 
which corresponds to cardiac systole, the pumping phase of the heart cycle. Reuptake of calcium 
produces relaxation, which corresponds to cardiac diastole, the filling phase of the cycle. 
The myocardium, the muscular component of the heart. Each cell has one or two large nuclei, 
occupying the central part of the cell, whereas skeletal muscle has multiple, peripherally placed 
nuclei. The cells are branched at their ends, and the branches of adjacent cells are so tightly 
associated that the light microscopic appearance is of a network of branching and anastomosing 
fibres. Cells are bound together by elaborate junctional complexes, the intercalated discs . 
Fibrocollagenous connective tissue is between cardiac muscle fibres, equivalent to the endomysium 
of skeletal muscle. Numerous capillaries and some nerve fibres are found within this layer. 
Connective tissue, equivalent to the perimysium of skeletal muscle, separates the larger bundles of 
muscle fibres, developed near the condensations of dense fibrous connective tissue that form the 
‘skeleton’ of the heart. 
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Longitudinal section about cardiac muscle cells show that the myofibrils are separate before they 
pass around the nucleus, leaving a zone that is occupied by organelles, including sarcoplasmic 
reticulum, golgi complex, mitochondria, lipid droplets, and glycogen. 
The cross-striations of cardiac muscle are less conspicuous than those of skeletal muscle. This is 
because the contractile apparatus of cardiac muscle lies within a mitochondria-rich sarcoplasm but 
the proportion of the cell volume occupied by mitochondria (approximately 35%) is even greater in 
cardiac muscle skeletal muscle. The high demand for oxygen is also reflected in high levels of 
myoglobin and an exceptionally rich network of capillaries around the fibres. 
The force of contraction is transferred through the ends of the cardiac muscle cells via the junctional 
strength provided by the intercalated discs. As in skeletal muscle, the force is transmitted laterally 
to the sarcolemma through the extracellular matrix via vinculin-containing elements, bridge 
between the z-discs of peripheral myofibrils and the plasma membrane. 
The sarcolemma of ventricular cardiac muscle cells invaginates to form t-tubules with a wider 
lumen than those of skeletal muscle; atrial muscle cells have few or no t-tubules. Unlike skeletal 
muscle, most t-tubules penetrate the sarcoplasm at the level of the z-discs . The t-tubules are 
interconnected at intervals by longitudinal branches to form a complex network. They probably 
serve a similar function in skeletal and cardiac muscle, i.e. To carry the wave of depolarization into 
the core of the cells. The actin-binding proteins, spectrin and dystrophin, are important components 
of the cardiac muscle cell cytoskeleton, which associate independently with the sarcolemma to 
provide mechanical support. 
Sarcoplasmic reticulum which bears junctional processes has been termed junctional sarcoplasmic 
reticulum, to distinguish it from the free sarcoplasmic reticulum, which forms a longitudinal 
network. Reticulum junctional sarcoplasmic makes contact with both the t-tubules and the 
sarcolemma (of which the t-tubules are an extension). Sarcoplasmic reticulum forms small globular 
extensions (corbular sarcoplasmic reticulum) in the vicinity of the z-discs, but not in immediate 
relation to t-tubules or the sarcolemma. 
 
1.2 Intercalated discs  
Intercalated discs are unique in cardiac muscle. In the light microscope they are seen as transverse 
lines crossing tracts of the cardiac cells, they have step irregularly within or between adjacent tracts. 
At the ultrastructural level these structures, which are complex junctions between the cardiac 
muscle cells, are seen to have transverse and lateral portions. The transverse portions occur 
wherever myofibrils abut the end of the cell, and each takes the place of the last z-disc. At this 
point, the actin filaments of the terminal sarcomere insert into a dense subsarcolemmal matrix 
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which anchors them, together with other cytoplasmic elements such as intermediate filaments, to 
the plasma membrane. Prominent desmosomes, often with a dense line in the intercellular space, 
occur at intervals along each transverse portion. This junctional region is homologous with, and 
probably similar in composition to, the structure found on the cytoplasmic face of the myotendinous 
junction, and is a type of fascia adherens junction. It provides the connection between cells for 
transmission of contractile force from one cell to the next. 
The lateral portions of the intercalated disc runs parallel  to myofilaments, long axis of the cell, for a 
distance which corresponds to one or two sarcomeres, it turning again to form another transverse 
portion. The lateral portions contain gap junctions, which are responsible for the electrical coupling 
between adjacent cells. Conductance channels within these junctions enable the electrical impulse 
to propagate from one cell to the next, spreading excitation and contraction rapidly along the 
branching tracts of interconnected cells. In this way the activity of the individual cells of the heart is 
coordinated so that they function as if they were a syncytium [2].  
 
 
2. Heart development 
The earliest progenitors of the heart are located in cardiogenic fields in the splanchnic layer of 
anterior lateral of mesoderm plate. The first morphological sign of heart development begins when 
two bilateral troughs of of myocardium called endocardial tubes are brought to the ventral midline 
during closure of the ventral foregut. The borders of cardiogenic fields form myocardial troughs 
that are brought into apposition to fusing at the ventral midline, forming the future outer curvature. 
After fusion of the endocardial tubes that the arms of the w-shaped myocardium fuse just beneath 
the foregut form the dorsal midline seam of myocardium that will become the inner curvature and 
dorsal mesocardium, thus creating the primary cardiac tube. In this process, the myocardium 
secretes thick acellular matrix called cardiac jelly that forms a layer separating the myocardium and 
the endocardium [3]. Because the heart begins to beat while the myocardium is still a tube, the 
functional development of the myocardium is a critical step. This involves development of 
appropriate channels to allow electrical currents to be propagated through the myocardium himself.  
Signals from to the endoderm anterior (cranial) induce a heart region forming region, overlying the 
splanchnic mesoderm and they inducing the transcription factor NKX2.5. The signals require 
secretion of BMPS 2 and 4 secreted by the endoderm and lateral plate mesoderm. Concomitantly, 
the activity of WNT protein, secreted by the neural tube, must be blocked because they normally 
inhibit heart development. Inhibitors (crescent and cerberus) of the WNT proteins are produced by 
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endoderm cells immediately adjacent to heart forming mesoderm in the anterior half of the embryo. 
The combination of bone morphogenetic protein (BMP) activity and WNT inhibition by crescent 
and cerberus causes expression of NKX2.5, the master gene for heart development. Bmp expression 
also upregulates expression of FGF8 that is important for the expression of cardiac specific 
proteins. NKX2.5 contains a homedomain and a homologue of the gene tinman that regulates heart 
development in drosophila. Tbx5 is another transcription factor that contains a dna-binding motif 
known as T-box. The phase of cardiac looping is dependent upon several factors, including the 
laterality pathway and expression of the transcription factor PIZX2 in the  lateral plate mesoderm 
on the left side. PIZX2 may play a role in the deposition and function of extracellular matrix 
molecules that control looping. In addition, NKX2.5 upregulates the expression of HAND1 and 
HAND2, transcription factors  expressed in the primitive heart tube. Downstream effectors of these 
genes participate in looping cardiac. Hand1 and Hand2, regulated by NKX2.5, also contribute to 
expansion and differentiation of the ventricles [4]. Most of cells that will differentiate in the 
developing myocardium are derived from a population of progenitor cells located in the pharyngeal 
mesoderm, termed the secondary heart field (SHF). Cells belonging to the pre-cardiac mesoderm 
differentiate into early cardiac progenitors which can in turn to differentiate in primitive 
cardiomyocytes, smooth muscle cells and endothelial cells. Known markers such as pre-cardiac 
cells of the primary and the secondary heart field are NKX2.5 and GATA-4. The expression of 
these two transcription factors is noted common in the LIM HOMEOBOX transcription factor 
positive (Isl-1+) of cardiac progenitor cells (CSC) in the developing pharyngeal mesoderm as well 
as fetal and post-natal mice hearts. This small number of isl-1+ cells has been identified as a residue 
of migrating SHF cells and  considered as resident progenitor cells in the myocardium in post-natal 













3. The stem cell 
Stem cells have generated more public and professional interest than other topic in biology. Stem 
cells attract the attention of many  because understanding their unique capacity may provide a path 
toward therapy for a variety of degenerative diseases. Although studies about stem cell biology are 
several, there is still a conflicting options on the nature of stem cells. This confusion can be partly 
attributed to the sometimes idiosyncratic terms and definitions used to describe stem cells [7]. 
The first work carried out in the early 60s by Till and McCullough [8] on hematopoietic stem cells 
of mice have laid the bases for all subsequent strategies stem cell research. This work, in fact, 
pointed to the conceptual paradigms that still makes use of the scientific community to design 
research and clinical applications. 
Stem cells are defined functionally as cells that have the power to self-renew as well as the capacity 
to generate differentiated cells[9]. Particularly, stem cells can produce daughter cells identical to 
their mother (self-renewal) as well as generate progeny with more restricted potential (differentiated 
cells). This simplistic and broad definition may be satisfactory for embryonic or fetal stem cells that 
don’t endure for the lifetime of an organism [10]. 
In recent years, several models have been proposed, which clarify the behavior of the stem cell : 
1) the stem state model 
2) the phase space model  
3 ) the chiaroscuro stem cell model[11] 
In the stem state model the cell enters a state stem of the reversible type that could bring a result 
variation of the concept of stem cell, implying that stemness would be a state rather than cell entity : 
from cellular entity to a true state [12]. In the phase space model is developed starting from the 
analysis that in stem cell biology, " a principle, still unclear, where it isn’t possible to measure the 
differentiation capabilities and the proliferative ability of a cell, since the evaluation of these 
properties would result in the irreversible alteration of the other [13]. 
An effect of this alternative model, which input its principles on continuous variables, is that the 
outcome of the division of stem cell must be described by a probability function, rather than a 
discrete probability distribution. Therefore, the cell that is generated by the division of a stem cell 
may have more skills and attitudes stem than the mother cell (de-differentiation). Morover, in this 
model, the concept of self-renewal is replaced by the concept of renewal of the population, while 
the plasticity of stem cell isn’t only possible but it is a fundamental trait of stem cell . 
In the model chiaroscuro there isn’t a classification in "progenitor/stem cell", but rather a reversible 
continuum. This may depend on the variability of chromatin and various genes expressed during the 
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cell cycle. Following this pattern, the imput of  a primitive cell in the cell cycle will match to a 
variation of the expression of adhesion molecules, cell surface antigens, cytokine receptors,  and a 
set of variations that cause the possible modulation of complex functions, such as the ability to form 
progenitors, the homing and engraftment in tissues [14]. Then have been analyzed the ability of 
these immature precursor cells that can potentially differentiate in a multilineage, where stem cell 
plasticity, however, is believed to be a "not proven properties that stem cell tissue possesses, able 
increase its power in response to physiological demands or insults. According the stem cells 
differentiation capabilities,  are classified as: 
• Totipotent (able to generate all the cells and tissues that organize the embryo including 
extraembryonic membranes such as the placenta and umbilical). Generically embryonic 
cells retain this property up to 4-5 days from the composition of the zygote ; 
• Pluripotent (originators of the cells of the three germ layers) ; 
• Multipotent (generate cells that are derived from the same germ layer) ; 
• Tissue-specific (retain the ability to originate own cells of the tissue in which they reside) 
Therefore, the difference between totipotency and pluripotency is the ability to form an entire 
organism in vivo, while germline competence is the main difference between toti/pluripotent cells 
and multipotent cells. Consequently, if we adhere to this definition, embryonic stem cells (ESC) are 
pluripotent, while fetal and ASCs can be considered, with the exception of spermatogonial stem 
cells multipotent [15]. The ESCs could be a possible source of cells with infinite capacity, self-
healing, which can in turn give rise to all the somatic cells and germ cells of an organism but are 
still significant obstacles to ethical and biological agents in the use of stem cells embryonic that led 
to the search for other possible sources of undifferentiated cells defined by their abilities to self 
renew and differentiate into mature cells. Stem cells found in fully developed tissues are defined as 
Adult Stem Cells (ASC). The function of ASCs is the maintenance of adult tissue specificity by 
homeostatic cell replacement and tissue regeneration [16]. ASCs are presumed quiescent within 
adult tissues, but divide infrequently to generate a stem cell clone and a transiently-amplifying cell. 
The transiently-amplifying cells will undergo a limited number of cell divisions before terminal 
differentiation into mature functional tissue cells. The existence of ASCs has been reported in 
multiple organs; these include: brain, heart, skin, intestine, testis, muscle and blood, among others 
[17]. Effective functioning of the body’s tissues and organs depends upon innate regenerative 
processes that maintain proper cell numbers (homeostasis) and replace damaged cells after injury 
(repair). In many though not all tissues, regenerative potential is determined by the presence and 
functionality of a dedicated population of stem and progenitor cells, which respond to exogenous 
cues to produce replacement cells when needed [18]. 
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4. Adult stem cell and stem cell therapy 
In order that the ideal customized stem cell therapy to be efficacious have to be realized four terms. 
First, stem cells used in these therapies have to be genetically stable and epigenetically controlled to 
ensure the safety of stem cells used in any future therapies. This is indispensable to ensure that 
patients undergoing stem cell therapy are not exposed to greater risks of tumorigenesis and other 
mutagenic illnesses. Second, stem cells should be capable to elude the innate immune response of 
patients, perhaps through the secretion of immunosuppressive molecules that impede immune 
responses or by showing host cellular recognition markers. The attendance of transplanted stem 
cells is essential for the strategy of an effective therapy. Moreover the capacity of transplanted stem 
cells to avoid immune detection and inflammatory responses will prevent undesired symptoms such 
as graft-versus-host-disease in patients. Third, stem cells employed in these treatments should be 
location specific. These stem cells should have specific  cell surface markers, where the homing 
will consent them to locate and migrate to specific localities [19]. Over the last years proofs on the 
probable presence of stem cell plasticity have been showed [16]. Numerous mechanisms, 
responsible for this property, have been suggested, among others, cell fusion [20], the persistence of 
usually multipotent cells in adult tissues, and the aptitude of ASCs to de-differentiate, obtaining 
higher degrees of stemness [12, 13]. Considerate these latter two premises, scientists have analyzed 
whether adult mammalian tissues could host multipotent cells whose differentiation potential was 
not delimited to the germ layer of their origin. Molecular signals for pluripotency, genetic 
reprogramming of ASCs, and widely multipotent [11]. Recent studies in the literature indicates the 
possibility of obtaining stem cells from sources of different origin, accordingly it has been possible 
to study their different capacity to give rise to different cell types using as a starting point a 
multicellular organism. So the study of Adult Stem Cells (ASC) originates from different types of 
tissue such as the bone marrow, the dental pulp, neural progenitor cells, the blood that flows from 
the umbilical cord, the amniotic fluid cells, etc. Nevertheless, the ability to undergo a differentiation 
process of an adult cell is only partial, and generally can only form only types of cell similar to the 
progeny of origin of the tissue where it originated (multipotent stem cells). A long time of ASCs 
have been widely used becoming a viable alternative in the context of uses in the therapy with the 
use of cells, several preclinical studies have pointed out that the use of undifferentiated precursor 
cells has shown encouraging results for as regards the type of bone marrow transplant autologous or 
increase in cardiac function after myocardial infarction and chronic coronary artery disease [21]. In 
animal models of the Thomas Moon group and in the case of spinal cord injury, the use of ASCs 
have provided a substantial improvement of the capacities of sensorimotor type [22]. Yet, in most 
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cases, the positive outcomes have subjected a serious risks, such as showed in other laboratories, 
which is given by the protocols able to provide positive results but are not may be included 
completely in order to be provide a result only one capable of being used in clinical practice. In 
addition, the functional recovery could be attributed, in some situations, to events of cell fusion or 
following release of paracrine factors that may intervene in the signaling between adjacent cells to 
support so the start of differentiation processes [23]or inhibition of apoptosis [24]. In some cases, 
highlighted by the work of Thomas of 2011 has been documented that the possible functional 
recovery could also be due to phenomena which affect the survival and differentiation of 
transplanted cells [22]. Several clinical studies have employed the ASCs in various different types 
of pathological processes such as the treatment of heart disease[25], in diabetes [26], lesions of the 
spinal cord [27], in disorders affecting the nervous system [28], in diseases of the liver and 
intestinal [29], lesions of the retina and neuromuscular dystrophies [30]. In this studies, mentioned 
above, the cells whose origin is unipotent and tissue-specific, originate from different sources 
depending on the condition treated, they were noticed evident, but, reduced improvements of health 
conditions that once again, raising many doubts on positive results. The results obtained could have 
been attributed to both the differential properties of the injected cells, in addition to the effects of 
anti-inflammatory certainly not secondary, that to paracrine action are able to reform a specific 
network that takes active part in the healing process [31]. In contrast, human ESCs derived from the 
inner cell mass (ICM) capable of developing in the embryonic stage starting from the blastocyst 
stage, which are able to expand indefinitely in vitro cultures, where they show in an indefinite 
manner the undifferentiated state. It was highlighted by most research groups their ability, in 
specific culture conditions to differentiate in cell types representative of the three germ layers: 
ectoderm, mesoderm, and endoderm. However, a characteristic emerged in various works, during 
and subsequent to the use of ESCs is their ability to give rise to teratomas when they are injected 
into immunocompromised mice, the ability to create masses abnormal cell [32]. The difference 
between ASCs and ESCs is due the first cell represent a source with further development capacity 
but especially as regard their use in cell therapy where their differentiation potential is certainly 
much higher. As early as 1988, with the work carried out by Thomson, has gradually increased the 
interest addressed to the embryonic cell lines due largely to their number that registered has seen a 
rapid increase, and more than 800 different ESCs human lines are now available at present [33]. 
Contrary to their differentiation potential, the use of human ESC research and cell therapy has been 
controversial because of various implications such as of a political, religious and ethical issues 
regarding the use of human embryos. In fact, much of the public opinion always deployed against 
research on ESCs largely due the use of preimplantation embryos should have the same right to life 
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as any person, regardless of whether we are talking about crops in vitro or during gestation. But 
now the discussion about the origin and the ethical use of human embryos was mostly passed in 
permissive countries such as China and Belgium, where embryos created in clinical practice of in 
vitro fertilization, are used for the study and the development of human ESCs, thanks to the 
informed consent of the parents [34]. The most important problem concerning the use hESC-based 
therapy is related to its clinical safety, more specifically, the intrinsic potential of pluripotent cells 
to originate teratomas or teratocarcinomas when injected into the patient [35]. But as explained 
above, several recent studies have pointed out an unexpected development potential of ASCs tissue-
specific. In fact, most work on the activity of multipotent stem cells in adult tissues have raised 
many hopes, these could represent an alternative source and more acceptable from the standpoint of 
regeneration. Even here there remain many questions about the nature and status of stem cells, both 
in vivo and in vitro, and their ability of proliferation and differentiation. ASCs represent one of the 
first successes of the experimental therapy with human stem cells. There are several reasons why 
ASCs collect a greater number of consents within the framework of cellular therapies compared to 
immortal cell lines or embryonic pluripotent cells. The therapies with ASCs are often of autologous 
origin with a risk for a possible immune rejection that is reduced to a minimum. The most of the 
studies carried out, the use of ASC imply that have undergone a number of probable genetic 
mutations minimum with a reduced chance of chromosomal aberration. ASCs were seen also in 
large tumors when tested in vivo. Finally, in the last years,the use of ASCs in therapy isn't 
considered controversial since they can be easily extracted from the tissues of the patient and don't 
require the destruction of embryos, these advantages of ASCs have led to their wider use in research 
and in various clinical settings [19]. For example, the epidermis is a tissue capable to rapid and 
persistent self-renewal. Indeed when it is exposed to UV radiation and other chemicals, start a 
mechanism of self-renewal. The latter may take place thanks to the presence of the cellular fraction 
in active development but unipotent. The epidermis have a single inner layer (basal) of dividing 
cells, which cyclically come out from the replicative cycle, terminally differentiate and migrate 
towards the outside, on the skin surface [36]. In response to injury, the stem cells of edematous 
surrounding regions are activated, and these leave these areas, migrate and contribute to 
repopulation of the epidermis. In addition, even the cells derived from bone marrow  contribute to 
the regeneration epidermic and differentiate in keratinocytes [37]. The bone marrow serves as a 
reservoir for different types of stem cells, including hematopoietic stem cells (HSC), endothelial 
progenitor cells (EPC) and mesenchymal stem/stromal cells (MSC)[38]. MSCs are one of the first 
attempts of adult multipotent cells to use in stem cell therapies. These stem cells have the ability to 
differentiate into various types of tissue such as bone, cartilage, and adipose tissues. While the bone 
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marrow is the most common source of MSCs for clinical use, also can be found in various areas 
including adipose tissue and synovial fluid, skeletal muscle, peripheral blood, umbilical cord, etc. 
[39]. The mesenchymal stem cells indicated a heterogeneous population of cells that showing 
differences in proliferative capacity, cell markers, and morphological aspects. For example, bone 
marrow-derived MSC (M-MSC) have a lower proliferative capacity, compared to the mesenchymal 
stem cells of adipose tissue (A-MSC) and from umbilical cord blood (U-MSC), which have the 
highest proliferative capacity [40]. MSC also have different differentiation potentials. For example, 
the bone marrow MSCs have a higher potential chondrogenic while the adipose tissue MSC have a 
low potential chondrogenic [41]. Moreover, both the bone marrow MSC and adipose cells form 
phenotypes adipogenic unlike cord blood that show a lesser ability to form adipocytes [42]. MSC 
also express different cell markers. For example, A-MSCs express CD34, CD49d, CD54, while M- 
U-MSC and MSC show higher levels of CD106 [43]. M-MSC and A-MSC also have higher levels 
of CD90 and CD105 expression compared to U-MSC [40]. The morphology of the mesenchymal 
stem cells may also differ significantly, in the literature are indicated various morphological 
characteristic such as, spindle shaped, round, fibroblastoid cells, flattened cells, and blanket cells 
[44]. Further studies to understand the differences in various subpopulations of mesenchymal stem 
cells could lead to a better understanding about epigenetic differences that regulate stem cells and 
their fate differentiation, homing to specific recognition sites, the rates of proliferation and 
senescence. M-MSC are currently being used in clinical trials and therapies. In fact, one of the main 
reasons to the success of therapy with the use of M-MSC is due to their intrinsic 
immunomodulatory properties that allow to inhibit and evade the danger of a possible immune 
rejection when transplanted [45]. M-MSC are able to inhibit the maturation and function of various 
immune populations such as dendritic cells, natural killer cells, B and T lymphocytes [46]. 
Furthermore, the M-MSCs have a low immunogenicity due to the reduced surface expression of 
MHC proteins ІІ and the lack of stimulatory proteins such as CD80 and CD86 [47]. Another 
important reason of the initial success of therapies based on M-MSC is these cells have low 
oncogenic potential and therefore a low risk of forming tumors [47]. Moreover, the presence of 
ASCs within specific niches is important to the possibility of maintaining a sufficient 
communication and active within the environment which ensures a high reactivity in the activities 
of cell turnover and repair following to damage. In many tissues, the balance between protection 
and interaction factors appears to be crucial to maintain ASCs in a specialized microenvironment, 
or niche, which provides mutual influence from the point of view of time and space to support and 




5. Pathology of acute myocardial infarction: 
The traditional view 
The tradition vision of myocardial infarction is characterized an initial phase in which the 
cardiomyocytes undergo apoptosis starting from the innermost layers of the endocardium. When the 
blood supply doesn’t occur in the first 6 hours, the result that follows is necrotic site around to the 
occluded artery. The cardiac tissue loss starts a articulated process which has the purpose of 
repairing the damaged tissue and preserve the structural integrity. Different chemio-attracted factors 
arrive in the infarcted area and they work in the stage of tissue repair. Inflammatory cells in the 
lesion area quickly remove necrotic and apoptotic cardiomyocytes, release active mediators that 
lead to synthesis of new blood vessels that begin to sprinkle the infarcted area [49].This initial 
inflammatory phase is usually followed by a phase in which the fibroblasts come to border area and 
slowly invade the infarct region, give rise to the scar tissue. Instead, after the infarct the 
cardiomyocytes that remain functionals, to compensate for the loss of contractile tissue, become 
hypertrofic. In humans, the healing process lasts six to eight weeks, with progressive changes in 
ventricular size. However, the left ventricle remodeling and a large part of the heart tissue was 
believed to be irreversible, since the heart was been considered a postmitotic organ without any 
capacity for self- renewal. However, recent evidence on cardiomyocytes overtun this conception 
[50], in particular the discovery of stem cells tissue-specific resident in the adult heart in active 
phase of cellular cycle [51]. Indeed more papers indicate a possible clinical approach [52], rejecting 
the classic view classic where the adult heart is a postmitotic organ, suggesting an alternative 
therapeutic about myocardial infarct that supporte the heart regeneration and cell turnover .  
 
 
6. Tissue regeneration 
Stem and progenitor cells have been identified in most organs including, skeletal muscle, liver, 
lung, skin, kidney, blood, bones, reproductive tissues, intestines and heart. The function of these 
cells seems to be tied to a cellular homeostasis, in the phases of cellular turnover of or due to 
damage and replace so insure normal and correct functions of the organ. Some progenitor cells also 
can renewing the tissue after minor injury, or even after a major damage or removal. Relevant 
examples are given by regeneration in the blood and in the liver. Indeed, hematopoietic stem cells 
transplanted have a high ability to repopulate the hematopoietic system of an irradiated mice, and 
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the liver is able to renew its mass within two weeks after the removal of two-thirds of the whole 
liver tissue[53,54]. In the other hand, not all organs have the same degree of regeneration. The heart 
and the central nervous system are particularly resistant to regeneration after injury, for example, 
the brain, has a reduced propensity to regenerate in the case of neurodegenerative disease or 
stroke. For hundreds of years, biologists have been fascinated and inspired by the spectacular 
regenerative capabilities of different species. Some animal models of invertebrates such as Hydra 
and planaria have an unlimited capacity of regeneration, able to recreate a full head and a tail from a 
small piece of tissue [55]. Lizards, frogs and fish have been employed as models for vertebrate 
regeneration; yet salamander research in the work of Spallanzani in 1768 who was the first that 
indicate the ability of salamanders to regenerate an entire limb amputated [56]. 
 
6.1 Understanding heart regeneration in animal models: from adult to 
neonatal regeneration 
The study of the natural regenerative capacity of the heart tissue of amphibians has been examined 
in frogs, newts and axolotl, carried out as early as 1960 by leading Soviet scientists. The first data 
obtained, have shown that amphibians survive  after an extensive and severe damage to the 
ventricle, and further the removal of approximately one quarter of the ventricular portion. This 
resistance likely due to a lower degree of dependence of the blood circulation compared to 
mammals [57]. The scientific popularity of the zebrafish model has encouraged the research of its 
regenerative capacity. Zebrafish seven fins that can regenerate also after an amputation of the tissue 
until 95%. The caudal fin is often used in regeneration experiments, and completes regeneration in 
10-14 days. The process of fin regeneration is epimorphic, involving the formation and proliferation 
of an undifferentiated multipotent cells [58]. The simple structure of the fin, its external 
accessibility and the fact that his amputation doesn’t cause significant changes in lifestyle and the 
main reasons for its success as a organ model. Many groups have focused in understanding the 
events underlying the regeneration of zebrafish fin, with the aim of exploiting the tools and 
techniques developed by embryologists to apply them to problems and fundamental questions 
which regulate in particular the activation of regenerative properties of cardiac tissue in mammals 
and specifically in humans. 
 
6.2 The Amphibian Heart 
Unlike the mammalian heart, the heart of zebrafish form a reduced scar tissue and that compensate 
with a high regenerative response. Different important work suggests that after amputation of 20 % 
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of the apex of the ventricle, after the formation of fibrin clots, follows an intense regenerative 
activity that recreates the lost heart muscle in a period of 30 to 60 days [59] thus confirming the 
idea that implies a migration of cardiomyocytes through the heart [60]. One of the cellular pathways 
involved in cycle cell reactivation is definitely Notch that seems crucial for the reactivation of these 
cellular phases which remains inactive until activation of important pathways  for the formation of 
the heart [59]. Scientific networks have questioned the possible origin of newly synthesized 
cardiomyocytes in animal models of zebrafish, currently there are many papers in the literature that 
indicate that the new muscle doesn't come from differentiation processes of stem cells. Others work 
group suggest that there is a reactivation of the cell cycle in adult cardiomyocytes undergoing 
dedifferentiation and subsequent proliferation, such as demonstrated by several laboratories [61]. 
During genetic testing before mentioned, cardiomyocytes that dedifferentiate and that proliferate, 
they are characterized by re-expression of progenitor cardiac marker such as GATA4, by 
disassembly of the sarcomeres, and by formation of a mesenchymal-like phenotype infiltrate [60]. 
When the cardiac function is rehabilitated in zebrafish, it was seen that cardiomyocytes return to a 
state of quiescence after the migration in their site of origin. Not surprise that regenerative response 
involves a considerable amount of cardiomyocytes in active proliferative phase. Other groups show 
a basic level, when the zebrafish cardiomyocytes show a higher degree of activity of the cell cycle 
compared with their mammalian counterparts. In fact, one study showed that about 3% of 
cardiomyocytes, in the myocardium of adult hearts undamaged of Zebrafish, are able to absorb 
thymidine analogue bromodeoxyuridine (BrdU) during a seven-day pulse-labeling experiment.Two 
weeks after the amputation of cardiac apex, the fraction of BrdU-positive cardiomyocytes was 
increased tenfold, and this parameter remains to 20% even after 30 days from amputation [62]. 
Initial experiments have suggested that undifferentiated progenitor cells were the  main source 
regenerative in zebrafish cardiomyocyte, although lately other experimental data with genetic fate-
mapping experiments have shown that cardiac regeneration starts from pre-existing 
cardiomyocytes. The research on regenerative properties has been consistent over the last few years 
in zebrafish, but didn't clarify whether the processes as seen in amphibians are also possible in 
mammalian cardiomyocytes. In fact, in experiments carried out by Porrello and colleagues in 
2011[63], it has been observed a very similar regenerative response to that observed in Zebrafish in 
the hearts of neonatal mice. The rats subjected to 10% -15%  to amputation of ventricle were able to 
elicit a regenerative response in the first days of life (up to 7 days). Also here, the synthesis of new 
cardiomyocytes from cardiomyocytes pre-existing, such as shown by genetic approaches lineage-
tracing with genes Cre/lox, is involved in a complete cardiac activity with recovery after 30 days. 
The authors have reported many features in common with the zebrafish model, the presence of de-
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differentiation with the characteristic disassembled sarcomeres and the absence of hypertrophic scar 
tissue, the last characteristics typical of mammalian heart postinjure. Lately the group Porrello et al. 
has showed a model of ischemic myocardium in postnatal mice, demonstrating a robust 
regenerative response with the active proliferation of cardiomyocytes differentiated capable of 
supporting functional recovery in 21 days. Inside the animal model before mentioned, it was 
possible to analyze such as the functional inhibition of miR-15 has able to reactivate the cell cycle 
in cardiomyocytes supporting thereby the full recovery of ventricular systolic function after 
myocardial infarction[64]. Even the use of genetic manipulation techniques allow relevant 
similarities between zebrafish and neonatal mice models but also important differences. It is 
important to note that the zebrafish model provides a heart with a small percentage of adult 
cardiomyocytes compared to mouse studies where it is assessed with a heart actively growing with 
proliferative cardiomyocytes within a tissue infarction partially still immature and in the 
development phase. Despite the differences between evolutionary state and differentiation of heart 
in the two species is definitely remarkable the efficiency of the response also in neonatal rat 
cardiomyocytes in manner similar that seen in zebrafish. These observations suggest that pathways 
that lead to proliferation of adult cardiomyocytes are much conserved, hypothesizing so the 
beginning of studies on proliferative activity of heart tissue[62]. 
 
 
7. Cardiac regeneration in mammalian heart 
Acute myocardial infarction (AMI) is caused by the abrupt closure of a coronary artery due 
primarily to thrombus formation. The most effective therapy for AMI is represented by timely 
revascularization of infarcted area, with thrombolytic agents, with coronary intervention, or with the 
use of by-pass. With the advent of reperfusion therapies, the institution of intensive care units, the 
introduction of effective drugs such as beta-blockers and ACE-inhibitors, the occurrence of 
complications in patients with AMI has been reduced, life-expectancy improved. Despite these 
advances, AMI produces a high morbidity and mortality, especially in those patients who missed 
the opportunity for timely reperfusion. In patients with large infarcts, ventricular remodeling often 
leads to congestive heart failure (CHF). Recently, the use of stem cell in clinical practice has been 
indicated such as possible regenerative or reparative therapy for AMI. This clinical strategy is based 
on the hypothesis that multipotent stem cell types, that injected into the heart, will be able to 
repopulate the necrotic tissue and differentiate in new cardiomyocytes, promoting the function 
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recovery contractile. Stem cell therapy has also been tested in models of chronic myocardial 
infarction (CMI) and chronic ischemic heart disease (CIHD)[65]. Few are so far the improvements 
in human cardiac regeneration, though of great clinical impact especially in the prospects of 
improvement of quality life of affected people. Indeed, it is generally accepted that mature 
mammalian cardiomyocytes have a low capacity for cell division [66]. Studies in rodents have 
suggested that hypertrophy in cardiomyocytes lead to an increase in the size of the cells, as opposed 
of hyperplasia that brings an increase in the number of cells[67]. The paradigm that the heart is a 
postmitotic organ incapable of regenerating their parenchymal cells was established in 1970, and 
this dogma has profoundly influenced basic research and clinical research in cardiology probably in 
the last 30 years [68]. The heart failure is often the result of cardiomyocytes loss after the onset of 
events, such as myocardial infarction. The majority of patients hospitalized with heart failure have a 
similar prognosis to patients with common cancers [69]. With the difference that the organ 
transplantation or implantation, depending on the case, imply of assist devices mechanical 
ventricular, but currently further efforts by the clinical world have turned to find alternative to 
current therapies that don't resolve the central problem of decreased pumping ability of heart due to 
myocytes reduction. Thus, it was born an relevant interest in recent years from many networks, on 
the study of regenerative properties of heart. Until recently, the prospect of cardiac regeneration was 
considered by many in large part such as a concept of pure science fiction. The long-standing 
paradigm that stated that the mammalian heart is a terminally differentiated organ, it incapable to to 
initiate the cellular turnover. However, over the past decade, relevant studies have showed that 
cardiac myocytes of mammals retain of division degree[70], but highlight the presence within the 
bone marrow [71] and in particular in adult heart of cardiac progenitor cells [72]. A significant issue 
related to ability of heart to support the cardiac pathologies could be due to ability to start the 
infarction reconstruction in postnatal stage that represent an adult stage of the organ development 
with reduced proliferation capacity in phase postmitotica, limiting the response of heart with 
increase in workload. When myocardial hypertrophy exhausted its effects, can accumulate diseases 
such as ventricular dysfunction. Over the past three decades, the study of molecular cardiology and 
of the signaling pathways that regulate the activation and  the inhibition of gene transcription, was 
been essential to understanding the hypertrophic response in cardiomyocytes in early stages of 
physiological development, in aging and in pathological states of heart [68]. 
The mechanism that rules the ability of heart to renew its parenchymal cells has been rejected by 
many, and in fact the myocardial repair is viewed with suspicion but also with some trepidation. A 
new point of view promotes a biological perspective extremely interesting, indicated first by the 
group of Prof. Anversa, which in sick adult heart is demonstrated to degree of cellular regeneration 
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that occurs both in humans but also in animals after acute infarct [70, 73], after pressure prolonged 
overload [74], and in decompensated heart failure in aging [75]. Despite the intense scientific 
production and several data published over the last 20 years [76] and the new networks on cardiac 
regeneration, nevertheless, many researchers has rejected this alternative view on cardiac biology, 
safeguarding the old conception considered unshakable and immovable. But the conviction in some 
research groups that nothing could be done to generate new myocardium was so strong that only 
scientific results published in Nature in 2001 where new myocardial cells from bone marrow 
(BMC) were synthesized in necrotic tissue after myocardial infarction [71] call into question the 
view ancient point [77]. The controversy on myocardial regeneration by  undifferentiated cells with 
exogenous or endogenous origin, play on relevant comments about the history of the heart as a 
postmitotic organ are employed to understanding of  shift paradigm required for implementation of 
new field of regenerative cardiology. Numerous studies on human heart begins already in the first 
half of the 800 where the common thought was that the hypertrophy of the myocardium was the 
natural consequence of hyperplasia and hypertrophy in damaged cardiomyocytes. Scientific data 
where the myocytes weren't able to divide it was inspired by the complexity of determining mitotic 
figures within myocardial cells. they have gained the support of many in the early '20s thanks to 
experiments autoradiographic of incorporation of thymidine in hearts animals of during the post-
natal growth and after the occurrence of conditions of work overload [78]. In fact the results 
obtained doesn't show appreciable synthesis of deoxyribonucleic acid in nuclei of cardiac cells and 
thus it has been introduced in the scientific community that the dogma that heart survives and exerts 
its function, until the death of organism, with almost the same number of cells that are present at 
birth and that the increase in cardiac muscle mass in heart disease was the result of mechanisms of 
hypertrophy cellular [79]. In additiont he number of myocytes synthesized that established only few 
months after birth [79], and that cells themselves are considered able to contract 70 times for minute 
for a lifetime, could be a risked consideration that lead to consider the cardiomyocytes such as 
immortal cells both from the functional point of view that structural especially in centenarian 
subjects with an age greater than the average. This hypothesis contradicts basic concept that 
indicate cellular aging and cell death by apoptosis going beyond the simple logic which assign a 
slow but constant cellular turnover therefore capable of supporting normal tissue function during 
the life of the organism [80]. The observations carried out for decades have been challenged by 
experiments where was possible to identify male cells in female hearts transplanted. In these 
experiments hearts of women in male guest has a significant number of myocytes chromosome-
positive Y and the synthesis of new coronary vessels. Although there are differences between the 
groups about degree of cardiac chimerism [81], these findings have raised the possibility that these 
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cells could populate, both heart male and female, differentiating in myocytes and vascular 
structures. These early data were consistent with the thesis according to which stem-like cells can 
migrate to area of damaged heart and it give rise to progeny cardiac[80]. A new type of method to 
be used for replacement of traditional transplantation has been shown by research into stem cells, 
which have enriched the last decade our understanding of the biology of development and cell 
differentiation, providing a type of instrument alternative to organ transplant to correct degenerative 
diseases and tissue loss. The stem cell treatment seems to be interesting therapy for cardiac tissue 
damage[82]. Several mechanisms work together to contribute to improving cardiac regenerative 
capacity sometimes observed in mice, which is often associated to increased vascularity and 
proliferation cellular. Substantial studies indicate that activation of responses pro-rigenerative is 
realy possible in the hearts of mammals, but the mechanisms involved remain currently poorly 
understood [62]. Few answers to the many questions born of the understanding of the steps 
involved in cardiac regeneration were been definitively resolved. But the aspect that at moment 
seems to be certain is that regenerative percentage in human myocardium is quite insufficient to 
counterbalance the serious loss of heart muscle that occurs following an acute myocardial infarction 
or other myocardial diseases. The implementation of reduced regenerative mechanisms that exist in 
adult cardiac tissue of mammals, highlights the problem of physiological barriers, that may prevent 
the synthesis of new cardiomyocytes, such as they could be the onset of inflammatory and fibrotic 
phenomenon that characterize the various phases of the infarcted myocardium including ischemic 
phenomena. Some components of the inflammatory response might be essential for promoting 
angiogenesis and progenitor-cell recruitment, but excessive inflammation might also prevent the 
recruitment and survival of progenitor cells. Similarly, some degree of fibrosis is required to 
prevent myocardial rupture after a myocardial infarction, but dense fibrosis presents a formidable 
physical barrier to regenerating cells. Perhaps the most surprising aspect of the current progress 
towards cardiac regeneration is the wide variety of cell types that have been considered as 
candidates for tissue reconstruction become necrotic. The different cell types constituting the 
intricate structure of the heart involved in myocardial damage and in reducing the performance of 
the organ reflect the need to find a medical solution for the treatment of heart disease, and therefore 
giusticano the large amount of experimental efforts in development of cellular therapies targeted. 
It's important to underline that different are experiments carried out to study the different cell types 
able to support the reconstruction of lost or damaged tissue. Different cell types have been proposed 
and they studied with important projects for recovery of damaged heart: skeletal myoblasts [83], 
fibroblasts [84], SMC [85], fetal myocytes [86], ESCs [87], cells derived from bone marrow (BMC) 
[88], and cells, induced pluripotent stem cells (iPS) [89]. Fibroblasts, SMC, and fetal myocytes 
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form a portion of newly synthesized tissue with different criticality, it is showed which the decrease 
of stiffness in parenchymal tissue resynthesized, however, a positive effect on the ventricular 
remodeling is functional, creating a positive effect on the contraction. Also totipotent ESCs seem 
grow up in myocardium root but quickly die due to lack of new blood vessel formation  besides 
possible problems of immune rejection they are observed [90]. Important complications they are 
showed in some studies where it has been shown that the ES cells give rise to teratomas and 
teratocarcinomas [91]. Similarly, also the iPS cells were recently identified a potential carcinogen 
on their development ability, moreover these types of cells weren't considered for possible clinical 
uses .The advent of new technologies about (IPSs) the synthesis of pluripotent stem cells it offers a 
possible solution the problem to immune rejection. This technology involves reprogramming of 
adult human fibroblasts terminally differentiated into pluripotent stem cells where it is showed a 
expression of four pluripotency factors: Oct4, Sox2 c-MYC, and KLF4. The reprogrammed cells 
show many characteristic features of mature ESCs, morphology, cell surface antigens, gene 
expression, telomerase activity, proliferation degree, and  ability differentiate in cells of the three 
embryonic germ layers [92]. Since, the fibroblasts adults can be obtained directly by the patient, it 
is assumed that patient-specific IPSC cells, derived from the CM could be transplanted without 
immune rejection. But another barrier to iPSs-based therapy is the reduced time window to get cells 
patient-specific. Also taking advantage of the protocols currently accessible, iPSCs cannot be used 
in exigent circumstances, such as in context of myocardial acute infarction or heart failure 
progressive. It's also important to reminder that iPSCs were created using viral vectors, which 
increase the risk of genomic integration and an eventual potential oncogenic risks. A first attempt to 
replace infarcted myocardium with patch of skeletal muscle has been performed over the years 30. 
Later in the 80, layers of skeletal muscle tissue were placed on surface epicardial ischemic, 
stimulating the contraction with a pacemaker [93]. The way indicated above has formed new 
approach called cellular cardiomyoplasty and consists of direct injection of skeletal myoblasts in 
ischemic area. The cells autologous origin, inoculated in damage area, create a clear benefit in this 
type of cardiac repair. Moreover, the skeletal myoblasts, it is indicated, to be more resistants to 
ischemia compared to myocardial cells, in turn capable of support their chance of survival in 
necrotic myocardium. The use of skeletal muscle cells has been viewed by many as a viable 
alternative to transfer in clinical environment, thanks to data obtained in some experiments on 
infarcted patients subjected to this type of treatment [94]. However, the lack of integration of 
skeletal myoblasts within the myocardium creates more of a reason of apprehension about the final 
consolidation of their use in therapeutic practice. Indeed, the analysis of the interface graft-host in 
the area of inoculum, doesn't showed prove of mechanical or electrical coupling between cardiac 
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and skeletal muscle [95]. Specific markers of cardiac weave as connexin 43 and N-cadherin were 
detected in skeletal muscle cells injected, to which is added the increased synthesis of layer of scar 
tissue created between cardiomyocytes and skeletal muscle which is opposed to the grafting 
process. As has already occurred in some animal models by the group of Reinecke et al [95], the 
lack of synchronous contraction could be connected of responsible factors for arrhythmic events 
seen in patients treated with inoculum of skeletal myoblasts [94]. A further limitation to the use of 
skeletal myoblasts is represented by the initial phase of amplification in vitro, insufficient to meet 
the clinical requirements, this need represents a limit for clinical application in this procedure. This 
problem is particularly significant since it has been shown that success of use of skeletal myoblasts 
is directly correlated with number of donor cells. The need for a large amount of cells to be 
implanted is dictated by the fast cell death which undergo a large number of skeletal myoblasts with 
another important consideration which indicates the fast differentiation of myoblasts with synthesis 
of myotubes which limits any possible proliferation of inoculated cells [96]. Another cellular type 
are ESCs, prototype of stem cells. Able to meet all requirements of stem cells: clonality, self-
renewal and pluripotency. To grow and divide indefinitely while maintaining the ability to develop 
into all three germ layers. Under appropriate culture conditions, a small fraction of human ESCs (5-
15%) was seen spontaneously differentiate into cardiomyocytes with structural and functional 
properties characteristic of cardiac tissue [93]. ES cells can differentiate into any cell present in the 
adult and they have the potential to completely regenerate the myocardium. Several they showed 
the obstacles to therapeutic use of ESCs including the tendency to immunological rejection and the 
ability of ES cells to form teratomas when injected in vivo. This problem suggests the deepening of 
many paths that lead to the differentiation of ES cells, to study the alternatives to the limit that leads 
the teratoma formation where a possibility can be through the genetic selection of differentiated 
stem cells, or the in vitro differentiation of stem cells into cardiomyocytes and endothelial cells 
before injection, for example, utilization of tumor necrosis factor it was observed to promote the 
differentiation of ES cells into cardiomyocytes. Many groups believe that differentiated ES cells are 
able to survive and improve myocardial function if inoculated in the damaged myocardium but 
supported by different of tissue specific factors able to support cellular growth and differentiation. 
In some recent studies it has been studied the control of time proliferation and differentiation of 
ESC cells that could activated to sustain specific signaling pathways. For example, recent studies on 
rat and zebrafish embryos reveal the role of pathways of Wnt-catenin in cardiac development which 
can vary depending on stage of development [97]. Also in the field of ESCs, progress in 
understanding the pathways involved in gene regulation and epigenetics that leads to myocardial 
differentiation, have suggested potential new approaches to generation of cardiomyocytes derived 
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from undifferentiated cells useful for therapy. Effects regulators by some RNAs are indicated, 
microRNA (miR)-1 and miR-133, are specifically expressed in hearts of mice, and their deletion 
was targeted to phenomena of gene rearrangement with the result of creating a series of alterations 
in cardiac morphogenesis, in the electrical conduction in the cell cycle, and in cardiac hypertrophy. 
Different experiments have shown that transplantation of human ESCs in animal models of 
myocardial infarction gave low results until now to which are added the risks described first over, 
besides to problems of engraftment monitoring of the inoculum [98]. These results a complex 
indicate to partial creation of new tissue in the area infarcted creating cardio-specific incentives in 
the engraftment in vivo that appear not stable [93]. Non-resident stem cells, like BMSCs, were 
initially thought to adopt such as possible myocardial cell. Extensive research has published 
recently shown that therapies with nonresident BMSC are able to providing a cardioprotective and 
cardiogenic paracrine contribution in injured hearts rather than creating new myocardium cells.  
This type of cell therapy is used to facilitate cardiac repair through revascularization, producing 
positive physiological effects. In facts, BMSCs secrete angiogenic factors, activating several 
pathways involved in cellular proliferation. Many reviews it has been suggested that BMCs can be 
migrate in the heart, creating niches that might be involved in the physiological homeostasis of 
heart, it intervening both in the healthy organ that in regeneration of damaged tissue [99]. The 
specific contribution of this cell type in the processes of coronary vasculogenesis and 
cardiomyogenesis is currently little studied. Also some studies have allowed us to assess the 
chimerism degree in cardiac transplantation and in hearts of patients who received allogeneic bone 
marrow transplantation. In the latter case, 14-16% of myocytes and endothelial cells in transplanted 
hearts were found chimeric. These observations suggest the intracardiac origin of the recipient cells 
of donor heart and the extracardiac origin of chimeric cells in host heart after bone marrow 
transplantation. It have been suggested more than a hypothesis, in the first case, the host cells can be 
migrated from strains atrial residues to the heart of the donor and, in the second, the donor cells may 
have reached the myocardium due to high level of blood chimerism [100]. This particular cellular 
type of hematopoietic origin but with a cardiac differentation cardiac can be detected only when the 
peripheral blood contains a large number of hematopoietic stem cells (HSCs). Experimental results 
support this theory. The experimental test that HSCs were been able to induce regeneration after 
myocardial infarction, was obtained from the experiment when BMCS mononuclear cells and 
CD34-positive were administered to patients with various cardiac diseases such as acute myocardial 
infarction and chronic dilated cardiomyopathy, and refractory angina. The results though still under 
study, to which is added a certain degree of variability between studies, indicate that BMCs are able 
to procure therapeutic effects in subjects before indicated with a 3-4% increase in ejection fraction. 
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The safety in the mechanisms involved in therapy of BMC on humans remains to be confermed. 
Ratings on coronary blood flow suggest, however, that in the phenomena of vasculogenesis there is 
probably the release of active cytokines that you think would be probably decisive for the activation 
of one of the new growth target in the cardiac cell therapy such as the activation of cells resident 
stem in the adult heart (CSC) [96].  
 
 
8. Cardiac stem cell 
The recent identification of CSCs has shifted the attention on endogenous cell mechanisms about 
the reactivation of cardiac cellular development in adult organ such as a novel target of cell therapy 
for the failing heart. Different groups have isolated cardiac stem and progenitor cells from the adult 
mammalian heart. For the purpose of easier understanding have grouped in the same acronym the 
cardiac cells that appeared with characteristics progenitor and stems (CSCs). However, the 
difference between these two cell types is minimum. Many network of research on cardiac stem cell 
determine this cell such as a primitive cell, clonogenic, self-renewing, and multipotent, and it 
capable of differentiating into the three main cardiac lineages: myocytes, smooth muscle cells 
(SMC), and endothelial cells (EC). In contrast, a progenitor cell is an proliferating cell immature 
capable of differentiating into only one of the three above-mentioned lineages (myocyte or SMC or 
EC) [97]. The difficult recognition of cardiac stem cells and the singularity of their antigenic 
characteristics still remains a much argument discussed, in fact the stem characteristics can be 
identified in the delimitation and in the identification of functional characteristics of adult cardiac 
stem cells relate to inherent ability of the cell to self-renew, to clone and express different 
phenotypes mature ( multipotency ) in vitro and in vivo. The propensity the autorenewal, in fact is 
the ability of undifferentiated cells to divide indefinitely without errors during DNA replication. 
Furthermore, the daughter cells, that originate, have the same tissue-specific properties of the 
mother cell. In fact, the accumulation of mutations through the life, leads to aging of stem cells and 
affect the functionality of ASCs [102]. A typical example of accumulation of mutations occurs in 
the case of CSC mature in telomeric sequences of about 10 kilobase pairs, after each cell division 
occurs a subtraction of about 130 base pairs in length telomere, this could to have negative effects, 
as indicated by several research groups, on replicative capacity and further accumulation of 
oxidative damages in the DNA that occur during the cellular life cycle. The riduction of telomere 
25 
 
lengths may be reflected on the aging of CSC and the heart itself, reducing the possibility of action 
on cell turnover and thus on organism lifespan [103]. Similarly, clonogenicity, indicated as ability 
of a single cell to proliferate independently to form a colony, it is another specific feature found in 
adult CSCs, although still numerous are the limits of understanding of the capabilities of ex vivo 
expansion. Addition to two above mentioned properties, is added the multipotency, ability to 
generate distinct cell types from the same progenitor, in fact as mentioned above, the CSC have 
been shown a propensity to differentiate into the three main types of cardiac cells: cardiomyocytes, 
smooth muscle and endothelial cells. More than a marker antigens has been suggested in the 
identification about the regenerative potential stem cell and their relative interpretation in various 
classifications, that is still poorly defined. However, the study on replicative capacity and 
regenerative was analyzed in cells residing in the adult myocardium, where the selection markers 
directly related to stem cells are been identified such as factors cardiac transcriptions essential. The 
reference markers indicated in adult CSC are c-Kit (CD117) analyzed in cardiac tissue of different 
species such as rodents, dogs and humans, the protein MDR-1 indicated also as protein to multidrug 
resistance, and finally the Sca-1, antigen of generic stem cells. In murine animal models has been 
observed considerable increase of c-Kit positive cells after acute myocardial infarct. Even after 
inoculation, always in in vivo models of myocardial infarction, the cells c-kit seem able of 
regenerating the damaged myocardium, thereby improving cardiac function. In fact, c-Kit has 
different roles in the homeostasis of the organism, the Kit protein in CSC adult acts in development 
of bone, mobilization of hematopoietic progenitor cells, by decreasing the release of cytokines and 
chemokines that may participate in paracrine signaling with effects cardioprotective. Initial 
investigations suggested also which CSCs only transiently express c-kit, in rodents, and in humans, 
where is been found often the expression of Sca-1. A different subset of cardiac progenitors 
deriving from the secondary heart field, express the LIM-homeodomain transcription factor Islet1 
(Isl-1), identified in rodent but also in the human fetal atrium after greater outflow blood. 
Nevertheless, the continued study about the cardiac phenotype of CSC demonstrates the real need to 
define certain markers with antigenic model to redefine the universally accepted procedures for the 
manipulation of stem cells. However, c-Kit has been proposed such as unique marker for adults 
CSC capable of differentiating in contractile cells, while cells Isl-1 positives, also if it observes a 
certain degree of differentiation in cardiomyocytes and smooth muscle cells, they are detectable in 
murine animal models in murine fetal life, such as it observed in human beings, but not in adult 
stage. Conversely, progenitor cells Sca-1 positive weren't considered such as suitable for synthesis 
new cardiomyocytes. However, recent studies, show that Sca-1 is a stable marker of adult 
progenitor cells whose expression increases progressively in adult CSCs, suggesting a possible 
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hypothesis about the expression of SCA-1 linked to more mature of cellular development [102]           
Oh [104] and Matsuura [105] isolated Sca-1 positive cells from hearts of adult mice, and they have 
demonstrated that they can differentiate, in vitro, in different cell lines, including cardiomyocytes. 
The actual role of Sca-1 positive cells isolated from myocardium is still unknown, but it is possible, 
that are involved in cell signaling, in myocardial regeneration, although only 9% of cellular 
population Sca-1, were found also c-Kit positive. Others groups have isolated several cells with 
"immature" potentials in the adult myocardium, which  expressed c-Kit in different combinations;  
however, the cells c-Kit +/Sca-1+ constitute only a cellular subtype in the subpopulation of cardiac 
cells immature. Indeed, Anversa et al have suggested that CSCs classification and their progeny in 
three major subpopulations, it was based on the fact that they only express only c-Kit, only MDR-1, 
Sca-1 only, or a combination of these three markers and proposing a classification of the immature 
heart cells into four classes: CSC, progenitors, precursors, and amplifying cells. They suggest that 
co-localization of the expression of c-kit, Sca-1 and MDR-1 in primitive cells, but also that 
presence of an antigen does not exclude the others, or a combination of these (or c-Kit/Sca-1                  
c-Kit/Sca-1/MDR-1 or c-Kit/MDR-1 or MDR-1/Sca-1) can be expressed in individual clones [97]. 
Further evidence on presence of CSCs adult c-Kit positive, were obtained from rodents about 8 
years ago, where gradually have been outlined identifying characteristics of CSC c-Kit, such as 
clonogenic cells that divide symmetrically and asymmetrically in vitro, able to differentiate in 
cardiomyocytes and vascular cells. Newly formed cardiomyocytes, showed an increase of 
mechanical and electrical properties in functionally competent cells, improving the performance in 
the damaged heart ventricle, showing also regenerative abilities in a restoring the structure of 
infarcted myocardium [96]. Moreover, it is very important the idea that cell populations in the heart 
are grouped in cluster/progenitor stem cells capable of creating functionally competent 
cardiomyocytes and coronary vessels, consistent with the regenerative response observed after acute 
myocardial infarction and chronic pain in humans. In addition, it has been noticed in the 
transplantation of CSCs cloned in animal models of myocardial infarction, their ability to 
differentiate in vivo in a progeny with electricals, mechanicals that include the synthesis of calcium 
channels transients, typical of differentiated myocytes. The work of Braezi et al. in 2007 showed 
that the generation of cardiomyocytes is impressive and markedly higher than the numbers of cells 
lost chased to myocardial infarction. Furthermore, it was observed, the synthesis of marked 
coronary arterioles, events considered by many as one of the major factors capable of stimulating 
the formation of new myocardial tissue structurally and functionally similar to the parenchyma of 
neonatal heart, indicating the remarkable hyperplasticity of cardiac tissue of newly synthesized 
[100]. This specific population of stem cells, residing in specific anatomical areas called specialized 
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niches, which provide a microenvironment designed to safeguard the survival and activation of 
replicative potential of CSC residents in adult heart tissue [106]. The niche concept was introduced 
in 1978 by Schofield, who defined niche as a stable microenvironment that can control the behavior 
of hematopoietic stem cells [107]. Currently, the niche is seen as a subset of tissue cells and 
extracellular substrates that can indefinitely contain one or more stem cells and verifying via via 
their ability to self-renewal [106]. It is believed that the architectural organization in the niches of 
adult heart, provides several factors able to drive the differentation in different types of stem cells 
such as, CSCs mature, progenitors, precursors and cells in initial stage of differentiation. The role of 
niches is in turn connected with the surrounding environment through the expression of gap and 
adherens junctions. The specifics junctions, between CSCs and niches, are foundamental to transmit 
and receive signals from the surrounding tissue in phisiological stages such as cell survival, 
proliferation, but especially the induction to differentiate. Adherens junctions appear to be involved 
in maintaining the undifferentiated state of CSC. However, deregulation of the expression of 
connexins and cadherins, may alter the configuration of junctional complexes, influencing the 
growth and commitment of stem cells. The niches were detected in different sites of the wall of left 
ventricle indicating that CSC are, preferentially but not exclusively, present in protected areas of the 
heart. The formation of ventricular niches may be dictated, also by the migration of CSC from their 
sites of origin to damaged regions. The activation of the CSCs in order to migrate may be dictated 
by physical forces transduced in the ventricular wall in intracellular responses that regulate the 
cellular behavior and fate. It is important to emphasize that the abnormal pathological  loads may be 
associated with the start of the activation of active phase of replication, however, the peculiar 
topographical distribution of CSC in heart suggests that a relationship may exist between the 
function of CSC and the level of hemodynamic stress [96]. With the increase of work in CSCs 
adults have emerged a new area of cardiac research, also if it is one of the most controversial. Most 
of the work has focused on cell culture and transplantation, driven by clinical need for cardiac 
repair. In fact there are few reliable data to indicate the specific role of adults CSC in the 
spontaneous repair of damaged myocardium [108]. The inevitable evolution of ischemic injury is 
the formation necrotic myocardial with loss of mass and contractile function. In fact, the extent of 
spontaneous cardiac repair after infarction is minimal, the prevailing regenerative response is 
restricted to the non- infarcted tissue spared, [50] and the size of the scar formed negatively affects 
on the remodeling. Similarly, many believe that the regeneration in adult heart where it is believed 
that the loss of cardiomyocytes  is replaced by newly synthesized tissue, could regenerate new cells 
but not prevent or reverse the progression [74] of heart failure. The adaptation to heart failure and 
the pathological loads can reflected in the lack of mechanical transduction signals from the cardiac 
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tissue to the niches, it can lead then to lack of regeneration. Indeed, the absence of differentation in 
SMC, Endothelial cells, and myocytes, in some cases, could be linked to reduction of number 
niches with possible formation of voids and depletion of functional adults CSCs that could severely 
reduce the synthesis of cells important in regeneration cardiac with the result in excessive myocyte 
hypertrophy and altered coronary perfusion[96]. It is believed that maturation and survival of 
myocytes of new synthesis that invade the infarcted area both in relation to the availability of 
oxygen. There are two prerequisites for the successful integration of cells in the ischemic region 
[80]. Coronary arterioles and capillary structures must be formed in order to provide the necrotic 
tissue, restablish communication with large vessels of the normally perfused myocardium. In 
addition, the new blood flow through the vessels of new synthesis creates a vascular supply capable 
of permeating the myocytes, preserving their survival, favoring their growth, differentiation and 
contractile function [79].                     
At the moment, two clinical trials are underway in the United States : a study of intracoronary 
injection of CSCs in coronary heart disease with congestive heart failure so as to test the ability to 
reform new cardiomyocytes [109]. Instead other aims, such as assess the safety and efficacy of 
intracoronary delivery, was been examined an other form of CSC such as the Cardiospheres-derived 
(CSCs) from the patients with ischemic left ventricular dysfunction and a recent myocardial 
infarction [110]. In these two trials, stem cells are inoculated by intracoronary injection. However, 
the grafting of stem cells in infarcted myocardium without any structural support, it does not allow 
the cells to synthesize new tissue such as it was seen in papers where was showed that stem injected 
cells don't integrate properly in myocardium, not receiving the stimuli to grow or differentiate from 
the mechanical forces that are known to drive myocardial cell physiology [111]. 
 
8.1 Regenerative medicine and tissue engineering 
Cell therapy includes different branches of regenerative medicine, such as tissue engineering 
biological, where is provided the use of cell and tissue culture protocols for synthesize and increase 
of number specific cells to able of replace cells with functional alteration or completely lost, in 
various disease states. Major efforts have been directed towards two different strategies useful for 
the application of regenerative medicine based on the use of stem cells. The first involves the direct 
inoculation of a cell suspension into the bloodstream or into the damaged area of the target tissue. 
The second therapy, called "cell therapy", is made possible by the use of construct, similar to a 
fabric, formed by a three-dimensional matrix, which will be colonized by cells cultured in vitro and 
then subsequently implanted in the tissue of site recipient [112].        
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The concept that cell growth and survival could be recreated in vitro has been recognized as a 
possible almost one hundred years ago, when the German zoologist Wilhelm Roux, where has 
described a experiment with the neural crest of caught  and maintained in saline solution for few 
days, putting the foundations of mechanics of development supporting the functional adaptation of 
the various parts of the body. It's relevant indicate the tissue like an aggregate of morphologically 
similar cells that interact together to perform specific functions within organism macrosystem . 
Tissue repair can be understood such as the reconstitution of the architecture of  parenchyma but 
also of specific features which it carries on [113]. Therefore includes both regeneration processes 
that could ensure an alternative method of healing, where the growth of new tissue completely 
restores portions of damaged tissue returning them to their normal state. Systems that regenerate 
tissue repair and/or damaged tissue replacement, as defined above, identify complex systems that 
allow cell growth in natural or synthetic polymer matrices [114]. Langer and Vacanti have 
summarized that tissue engineering is an interdisciplinary area that applies the principles of bio-
engineering towards the development of biological substitutes with the purpose to restore, maintain, 
or improve the perfomance of the functional organ [115]. Tissue engineering is important for the 
synthesis of artificial tissue three-dimensional (3D). Indeed, the correct of biological and 
mechanical functionality is of great importance for tissue created in artificial structures, argument, 
this, still under development. It is of fundamental importance, to understand that the synthesis of a 
functional tissue requires a high efficiency of growth of different cell types within of scaffolds 3D, 
often it isn't supported for low number of cells, that appear in many works it is not adequate. The 
main function of scaffold is to regulate and guide the cell behavior such as migration, proliferation, 
differentiation, differentiation phenotype, facilitating the interactions between various types of cell-
matrix and cell-cell. The design of scaffold and the fabrication are major areas of biomaterial 
research, since biomaterial scaffold is the substrate within which cells are Instructed to form a tissue 
or an organ through a pathway highly adjusted [116]. A common approach in field of engineering 
techniques is the isolation of cell populations with a specific phenotype through small biopsy from a 
patient, increasing in number inside the scaffold, under controlled culture conditions. After the 
phase in vitro, the construct is placed in the desired anatomic site, with the aim of inducing the 
formation of new tissue where the scaffold rule the growth, but subsequently it will be followed a 
series of degradative events. An alternative approach is to implant the scaffolds for tissue growth 
directly in vivo, with the aim to stimulate and induce the formation of tissue in situ: the advantage 
of this approach is a reduced number of operations required [117], resulting in recovery in  time 
minor for patient. They distinguish grafts depending on the origin, in: 
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 Allografts: when the cells, tissues or engineered tissues derived from another individual of 
the same species . 
 Xenografts: when the cells, tissues or engineered tissues derived from another species (eg. 
heart valve devitalized from pig or bovine pericardium) . 
 Autografts: when the cells, tissues or engineered tissues derive from the same individual 
It's important the cellular kind, because tissue engineering techniques allow loading in polymeric 
matrixes (3D) (scaffolds) with differentiated stem cells to restore the original structure in damaged 
organs. For some years, encouraging results have been obtained in the reconstruction of tissues such 
as bone, cartilage, and in soft tissue, such as cornea and skin, while the greatest problems are 
represented in myocardium, between the most critical in the reconstruction in vitro. Currently, the 
type of autologous stem cells considered the best candidate for synthesis of bio-active substitutes, 
must be pluripotent and not induce a foreign body reaction [118].              
The main protocols of three-dimensional cell culture are directly related to  influence of cellular 
environment linked to basic aspects such as its dimensionality, stiffness, elasticity, composition and 
remodeling during the illness. Numerous studies have shown that the absence of extracellular 
matrix (ECM) and its main components such as fibronectin, collagen, laminin, aggrecan, etc. can 
lead to phenotypes, which altered in embryonic development and post-natal, have serious problems 
in their function [119]. In addition, recent discoveries such as Cdc42, important for the acquisition 
of the apical and basal polarity during morphogenesis or cell differentiation at the time of 
tubulogenesis, would not be rendered feasible without the EMC [120]and its three-dimensional 
characteristics able to create a specific microambiante for cell growth [18]. The attempt to induce 
the greatest efforts in synthesis of engineered scaffold that mimics ECM active, actively promoting 
tissue regeneration in vitro, as does the native ECM in vivo. Despite the incredible diversity of the 
structures of the ECM, due to the presence of different biomacromolecules and the system with 
which these are organized in space, in fact, a main feature native ECM is the nanoscopic size of its 
physical structures. In a typical connective tissue, structural proteins such as collagen fibers and 
elastic fibers have diametrical range from several tens to several hundreds of nanometers. The 
protein fibers clump together to form tissue structure which gives tensile strength and elasticity to 
tissues. Adhesive proteins, such as fibronectin and laminin use specific binding sites for cell 
adhesion, alike occurs exist between nanoscopic fibers and ECM. ECM in heart and in wall 
vascular includes fibrous proteins (collagen and elastin), adhesive glycoproteins (eg laminin, 
fibronectin) and proteoglycans. This organized network create in the ECM directs the development 
of cardiomyocytes, allowing a mechanical interaction between them and the adjacent network of 
capillaries and nerves, providing, also, an elastic support during the filling of the ventricular portion 
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[121]. The arrangement of proteins, in the cardiac ECM, is disposed such as relatively rigid fibrous 
rings that surround each heart valve. The collagenous connections between adjacent myocytes  
show the Z-lines sarcomeric across the cell membranes and it is relevant ensure the extension equal 
between cells contiguous while preventing slippage between of them. In fact, alteration of fibers 
collagen can decrease the myocardial systolic performance without to alter the contractility of 
myocytes [122]. A further consideration about the ECM is that cannot be considered as a passive 
tool, because it provides the organization microstructural to able regulate and direct the cardiac 
morphogenesis as well as myocardial function. For example, it has been observed already in 1988 
the elevated importance of the ECM in neonatal cardiomyocytes with a serious differences of their 
contractile properties to depending of type of substrate on which were grown which differed in the 
protein composition of the ECM [123]. So it is crucial to understand such as the ECM regulate the 
self-assembly of sarcomeres in differentiated myocytes, providing directional cues that guide the 
synthesis and placement of heart muscle myofibrils [124]. The understanding the way in which 
ECM interacts with tissues and cells allows to define the transmission of mechanical forces 
existing. It's important, concentrate the interest on receptors for integrins detectable on cell surface. 
Integrins are transmembrane proteins, dimeric structure with two sub-units α and β, linked to ECM 
proteins in extracellular and cytoplasmic such as actin-linker (eg vinculin, talin, α-actinin, paxillin 
and zyxin) or inside the cell, promoting mechanically the coupling between the integrins and 
cytoskeleton. Cardiac myocytes express various integrin receptor types that bind to collagen I 
(α3β1), to fibronectin (α3β1, α5β1) and laminin (α1β1, α3β1, α7β1). When integrins bind ECM, a 
change occurs in the conformation that leads the receptors to work together with specific protein 
kinases such as src kinase and focal adhesion kinase (FAK), and small GTPases such as Rho, on the 
cytoplasmic side of the membrane, supporting the assembly and the focal adhesion, between protein 
complexes of the matrix. These adhesion plaques specialized mechanically link the cell with the 
ECM, in which it stand include several clusters of integrins, proteins associated to molecules  actin-
linker and multiple signal transduction. Important to reminder, the focal adhesions play a central 
role in mechanotransduction, the process in which cells convert mechanical signals into 
biochemical responses [126].               
As pointed out in a review of 2012 by Karam et al. [127], the majority of cells transplanted in heart 
undergoes apoptosis in the early days after inoculation. Cell death in this particular situation is a 
phenomenon that has different and multiple factors that involves an inflammatory reaction in 
response to inoculation, apoptosis, ischemic conditions in response to reduced synthesis of the 
blood vessels and then poor vascularization and possible loss of contact between the cells and 
molecules of extracellular matrix (ECM). These issues have become critical in the last decade for 
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those that work on cardiac regeneration, through a continuous search to signals and  new strategies 
to improve the survival of cells inoculated.           
The strategies for tissue engineering are suggest in some studies where is been possible to make the 
combination between cell and biomaterials in the structure of scaffold, it is indicated in important 
results from group of Di Felice et al. [128] where they were shown encouraging results about to 
interesting perspectives for repair heart. Specialized branch of tissue engineering is certainly the 
heart  that aims to find solutions in specific case as the repair or regeneration of a damaged portion 
of the heart [129]. The biomimetic approach carried out by the CTE is to develop the production in 
vitro of immature tissues but functional, mimicking the key factors in native myocardium as the 
high cell density with multiple cell types, proposing expecially the diffusive transport of oxygen 
through network and an excitation-contraction coupling of fibers forming the newly formed tissue 
[130]. The design of 3D scaffolds for artificial tissues, tends to create a microenvironment that 
mimics the physical properties of the extracellular matrix as natural as the signals useful to the 
development of cardiac cells. Many are the qualities required for the scaffold such as the ability to 
not induce adverse immune response, a correct degree, also called "controlled biodegradability or 
bio-resorbability" and allow cell adhesion and migration, and dissemination of vital cellular 
nutrients. The cells that are on inside must be able to proliferate and differentiate, able to promoting 
tissue integration and vascularization, and, subsequently, to synthesize and organize a new ECM in 
time useful to organize the new tissue and to replace the artificial scaffold. The scaffold keeped in 
vitro or in vivo, is a structure capable of providing the necessary support for the cells to proliferate 
and maintain their differentiated functions, defining with its architecture the final shape of the 
intended tissue. Inevitably, the design and synthesis of a scaffold have become the main 
development areas in search of suitable biomaterial, covering a major role for tissue engineering 
and regenerative medicine research [116]. The more difficult task in the field of cardiac tissue in 
creation of new cardiac muscle, over the characteristics of biomaterials, there are but many adverse 
factors that counteract the realization, such as disease states in myocardial infarction and ischemia, 
where myocardial tissue puts in place a series of complex events such as an inflammatory acute 
state, the synthesis of granulation tissue, and the formation of scar tissue [131]. It observes the 
amplified synthesis of cytokines and growth factors that are released into the damaged area and in 
order to recruit white blood cells, neutrophils and macrophages. Macrophages are responsible for 
various processes such as the removal of apoptotic cells and necrotic from the infarcted area, in the 
recall of fibroblasts, endothelial cells and stem/progenitor cells, besides factors that lead to the 
synthesis of granulation tissue. The granulation tissue is replaced by new ECM synthesis, that 
differs from the normal condition mainly by fibroblasts that produce an area where we observe a 
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reduced number of functional cells compared to formation of granulation tissue. A fundamental 
understanding of relationship between the structure of the biomaterial and cell function in disease 
states is made possible thanks to numerous jobs in synthesis of structural tissues such as skin, 
cartilage, bone, and bladder [132]. 
 
 
9. Immunological behaviour to stem-cell 
based to cardiac repair 
The clinical use of cardiac stem cells has done emerge a number of issues regarding the 
immunological behavior after inoculation in host organism. Currently the problems recognized in 
the field of stem cell therapy for cardiac repair can be grouped into the following categories: 
teratoma formation, vascularization graft, cell viability in long term, integration in anatomical site 
and immune rejection of transplant. The immunogenicity of stem cells is often mentioned as a 
potential danger to the host, in fact, to date few have tried to address the issue even if current 
findings about inoculum of cardiac stem cells in immunosuppressed or immunodeficient animal 
models are still incomplete [133]. It's particularly important the state of inflammatory environment 
cardiac tissue damaged that you can be aggravated further to inflammatory reaction of host. The 
inoculum of cells from genetically unrelated organisms was been seen generate a robust immune 
response and, consequently, to increase the risk of transplant rejection. In stage initial, they was 
showed that T lymphocytes recognize foreign antigens in the form of peptides, they are presented in 
association with self molecules of major histocompatibility complex (MHC). Antigens of MHC 
class I are found on the membrane outer portion of cell nucleated able to show fragments of 
proteins synthesized within cell to cytotoxic T lymphocytes, or CD8+ T cells. In parallel, the MHC 
class II antigens are expressed only on a few specialized cell types defined antigen presenting cells 
such as macrophages, dendritic cells and lymphocytes B. Thus the function of the molecules MHCII 
is to present peptides of exogenous proteins to the T-helper lymphocytes, or CD4+ T cells . Are 
recognized different types of recognition such as the direct Allo-recognition where both CD8+ T 
cells that are stimulated by CD4+ antigen-presenting cells. The indirect allo-recognition occurs 
when non- self peptides are then processed and presented by MHC class II molecules of the host to 
be presented to CD4+ T lymphocytes. The presence of MHC molecules is the determining factor 
that largely determines the degree of rejection. Important considerations must been done before 
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inoculating that concern relevant problem such as the three phases of rejection. The three phases 
that distinguish the rejection are defined in: hyperacute, with a trend that occurs within minutes 
after injection or transplantation, activeted by self antibodies pre-existing that bind to cell antigens 
not self. This binding activates the complement system and a sequence that generate a different 
physiologic reactions of  response from the organism, such as an influx of mononuclear cells from 
the peripheral blood, the formation of platelet thrombi , and the inevitable destruction of transplant. 
Acute rejection, differently,occurs after more time about 1-2 weeks after transplantation, it is 
characterized by a high number of monocytes/macrophages, lymphocytes and dendritic cells that 
infiltrate in surface of contact between host tissue and inoculum. The third phase is the 
"hypersensitive rejection", in this reaction there is the action mediated by cytotoxic T lymphocytes. 
After, the last stage is the chronic rejection that occurs after a long period of time that can vary 
months or years after transplantation. Charateristic important of this reaction where is showed a 
relevant association with deposits of immunoglobulins and complement C3 molecules of cells 
inoculated [134]. The role played in the response to immune by cell transplantation is given by 
different biological and pharmacological agents implicated, whose role is important in the success 
of organ transplantation. Different pre-clinical studies were started with aim of studying cardiac 
regeneration by the inoculation of different tissue stem cells, including  iPS cells, MSC and human 
stem cells derived from amniotic membrane mesenchymal. In autologous transplant of iPS, 
mentioned above, cells have an reduced risk of a possible immunological rejection, but oncological 
risks are indicated such as higher than the normale, indeed it is to keep in account the presence of 
formations neoplastic masses unwanted [135]. An other cellular type such as MSCs II were detected 
the expression intermediate levels of human leukocyte antigen (HLA) class I and many are led to 
suppose that this particular cell is capable of withstanding a potential adverse immunological 
response as immunologically tolerated in the host heart.             
For the cure of myocardial deseases, in the last years, were indicated for potential  therapeutic use 
the CSCs autologous human for clinical protocols in patients with cardiomyopathy, and in 
particular two trials, such as Scipio and Caduceus, it were focused many attentions. In the first 
autologous cells c-Kit positive, differently in the second are used autologous stem cells obtained 
from Cardiosphere-derived to reverse ventricular dysfunction. Data obtained in both trials have 
provided the first evidences about feasibility of the utilization. Indeed, initial clinical results showed 
important and significative scientific evidence for a possible clinical utility [136]. However, a 
obstacle is indicated by immunogen response, intrinsic in host organisms. Allogeneic responses can 
lead to graft rejection largely that is mediated by cells CD4+ with pro-inflammatory phenotypes  
Th1 and Th2 [137]. An other cellular population that work in these phases cell type T are 
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lymphocyte CD4+ FoxP3+, they have important regulatory ability (Treg), adept at reducing the 
allo-immunity action [138]. The action of the two distinct lymphocyte populations indicates a high 
plasticity due to properties proinflammatory Th1/Th2 but also with tolerogenic properties Treg, 
thanks to subsets shown in 2001 by the work of Amarnath [139] in nude mice models.                           
Furthermore, additional results have shown that cells hypo-immunogenics because of inflammatory 
conditions and not, don't exhibit costimulatory molecules CD80/CD86 that were requests the 
stimulation of Th1 or Th2. In contrast, the expression the costimulatory molecules PD-L1, ensure 
the ability to limit the possible immune response due to stimulation of Treg cells. Patients with 
heart failure after myocardial infarction have showed the reduction of synthesis of Treg circulating 
cells [140]. The number of Treg cells has been shown to increase significantly, on the contrary, in 
conditions that reduce the environment physiological/pathological such as the myocardial damage, 
which is followed the inoculation of CSC and with their assets they stimulate the synthesis of Treg 
cells rather than proinflammatory cells. These results are fundamental to understanding the 
mechanisms involved in the immune rejection and reduce the possible risk and allow the persistence 
of repair cells in order to facilitate the repair/regeneration rate [136]. Even the complement is 
important component immune that plays an important role in the development and differentiation of 
CSC. An in vitro study was showed from Astiaso et al, such as the CSC cells express receptors 
anaphylatoxin functionals, that stimulation with C3a C5a induces the proliferation and the synthesis 
of CSC in addition to an increased activity of telomerase (NFκB -dependent). Taken together these 
data support a role for anaphylatoxins in healing rate and in the formation of scars. Indeed, apart 
from the role chemotactic known that C3a and C5a have on leukocytes , the anaphylatoxins are also 
chemotactic factors for other cells such as mesenchymal stem cells or neural stem cells [141].   
The MSC are among the most studied cells, about the influences after their inoculation in host 
tissue by immune system. It was observed that MSCs are able to interfere in the differentiation and 
function of dendritic cells (DC), which are considered to be antigen presenting cells (APC), playing 
a crucial role therefore regards the regulatory of responses cellular immune against self and non-self 
antigens. MSCs interfere in stages of endocytosis of DC, and affecting the ability of these cells to 
secrete interleukin-12 and to activate alloreactive cells T. Results obtained from different studies 
observe that the inhibition of molecules associated to the antigen presentation, such as CD40, 
CD83, CD80, CD86 and HLA-DR, during the differentiation of DC to following to the contact  
with MSC cells [142]. Additional scientific data are supported by other experiments in which MSCs 
inhibit the differentiation of naive CD4 T cells in T helper 1 (Th1). During T cell differentiation, the 
human MSC registers a significant decrease in the amount of IFN-γ (about 50 %). In contrast, when 
the cells MSC were present during the differentiation of Th2 cells , it was seen a significant increase 
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in synthesis of interleukin-4. These results indicate that MSCs can play an anti-inflammatory role, 
directing the profile of cytokines produced by these immune cells. MSC exert an inhibitory effect 
on the proliferation of B cells and on the differentiation of these cells into plasma cells.                               
In Addition, MSCs are been indicated to inhibit the chemotactic properties of B cells, because 
receptors for chemokine CXCR4, CXCR5, CXCL12 and CXCR4 were downregulated by the 
reduction of their specific ligand. When B cells are maintained in co-culture with MSCs,they are 
influenced by the immunomodulatory potential of MSCs. When MCSs were in co-cultured with 
NK-cells (stimulated by interleukin-2), there was a decreased secretion of IFN-γ from these cells. 
Furthermore, activating receptors: such as NKp30 and NKp44 were  seen downregulated in these 




















Biomaterial is one of the essential concepts that underlie the methods of tissue engineering, 
regarded in  biomedical applications to interact with biological systems.  The main functions of a 
biomaterial are numerous and how already outlined previously  favoring the complex cell - material 
and initiate a series of steps vital for the synthesis of new portions of tissue such as growth, 
differentiation, vascularization at the same time, it should allow for the replacement of the its 
structure with the newly formed tissue with a degradation rate equal to that of formation of new 
tissue, to be finally removed from the body by natural metabolic pathways without producing toxic 
by products [129]. The synthesis of the biomaterial is considered as the combination of synthetic or 
natural origin [143], with plenty of progress in various areas of chemistry, physics and biology were 
synthesized in new biomaterials with characteristics optimized for cell development in vitro and in 
vivo[144]. The biomaterials can be classified according to their performance and policies, such as 
polymers, metals, ceramics and composites. The polymers are probably the most biomaterials used 
in clinical practice. They represent the most important class of biomaterials in medical applications, 
because they have the best properties, in fact are inert, absorbable and easy synthesis compared to 
the other. In fact, the polymers may embrace a wide range of biomaterials with physical and 
chemical properties available in many different forms, including solids, fibers, films, and gels, to 
able to interact in conjunction with other materials or coated on the surfaces [145]. The 
characteristics and mechanisms that make them suitable for replacement of tissues, are simple to 
realize and may be engineered in an infinite ways for their characteristic chemical  in structure 
modular. The polymers are composed of very long molecules and flexible, formed by repetitions of 
simple units and from the monomer units, arranged between them due to covalent bonds. In turn, 
the long chains are held together by Van der Waals forces or by hydrogen bonds or, even, by 
covalent bonds called "crosslink"; addition, each chain may have other chains or side groups which 
influence the organization global. The polymers are arranged with chains partially ordered, 
acquiring the so-called semi-crystalline structure, characterized by regions where ordered crystals 
are immersed in an amorphous matrix. The basic parameter of the polymers is the degree of 
polymerization, which defines the average number of repeat units within a molecule, the increase in 
the degree of polymerization decreases the relative mobility of the chain and changes the 
mechanical properties of the polymer. For the study of these materials is important, also, to know 
their thermal characteristic, that is their behavior in function of the temperature. Polymers, natural 
or synthetic, are the largest class of engineered biomaterials that have probably the best chance to 
utilization in the reconstruction of the myocardial tissue. As well as their utilization in 
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cardiovascular systems, in orthopedics, in soft tissue and in dental implants because the polymers 
can be synthesized tailored in relation to the characteristics of the target site. However, it is reported 
in some cases negative aspects such as the absorption of water that could alter the polarity of the 
surface such as biodegradation and toxic reactions  unwanted that halt  their medical fitness[129]. 
One of the first considerations when designing a scaffold for tissue engineering is the choice of 
material. The three types of polymers most used with success are: (i) natural polymers, (ii) synthetic 
polymers, and (iii) ceramics [146]. Natural polymers are commonly derived, from protein or 
carbohydrate polymers, used as scaffolds for growth of different types of tissues [147]. Examples of 
natural polymers designed for biomedical application is the collagen.          
Collagen is considered by many scientists as ideal matrix for tissue engineering, structural protein, 
component of the ECM capable of retaining its shape after sowing or cellular infiltration in vitro 
and in vivo. It provides support to the connective tissues, such as skin, tendons, bones, cartilage, 
blood vessels, ligaments. Its influence is important in regulation of the activity of connective tissues 
supporting the transduction of signals essential for the regulation for the migration, proliferation, 
differentiation and cell survival. Ideal characteristics that resultant in vivo, are became interesting 
for in vitro use in design, such as high mechanical strength, good biocompatibility, low ability to 
induce an immune response by the host tissue and a percentage of mechanical degradation 
compatible with the formation of new tissue[148].                              
The collagen is synthesized in a variety of formats, including porous sponges, gels and sheets [147]. 
The chitosan, cationic polymer, obtained from chitin, comprising copolymers of β (1→4)-
glucosamine and N-acetyl-D-glucosamine. Chitin is a natural polysaccharide that is found mostly in 
the shell of crustacean, cuticles of insects and fungal cell walls and is the second most abundant 
polymerized carbon that is found in nature [149]. Presents a high adaptability of use which favors 
the use in the medical field especially in the administration of drugs. A other type of biomaterial are 
agarose and alginate, linear polysaccharides, are undergo numerous of purification reaction for 
avoid unwanted immune responses and of difficult health treatment, in vivo, after their implantation 
[146]. Their employment in clinical practice, has shown good attitudes in tissue engineering of the 
liver, nerves, heart, and cartilage. Drawbacks due by the use of alginate, are indicated mechanical 
weakness and lack of cell adhesion. To limit these drawbacks the composition of the alginate has 
been improved with unions with other materials [147].                                 
A biomaterial with discrete consensus is the fibronectin (FN), glycoprotein present on the outside of 
the cell membrane, such as other proteins of ECM, composed of tandem repeats of three distinct 
types (I, II and III) of individually folded modules [129]. A polymer produced by Bombyx mori, the 
cocoons of silkworms, originates a fascinating material of protein nature called silk fibroin (SF). 
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The SF is synthesized with natural fibers with comforting result about the resistant, attributed to its 
particular chemical structure of the protein itself. The amino acid sequence of SF contains repeated 
sequences of glycine-alanine-glycine-alanine-glycine-serine (GAGAGS) that self-assemble in a 
anti-parallel β-sheet structure. These β-sheets are highly crystalline, the disposttion of the is 
essentially crosslink, maintained through strong intra and inter-molecular hydrogen bonds, but also 
by strong Van der Waals interactions between stacked β-sheets, giving the material a high 
mechanical functionality properties. Advantages in use of SF, expecially, in biomedical applications 
include the excellent mechanical perfomance, slow auto-degradation process and good adaptability 
in hydrophilic environment. The synthesis of β-sheet domains with hydrophobic properties prevents 
the penetration of water and the slowing of protease activity with resulting in slow biodegradation 
of silk fibroin in vivo [150]. The silk fibroin has aroused increasing interest in the biomedical field 
for its stability in the tissue microenvironment thanks to excellent levels of biocompatibility, 
flexibility, morphological and mechanical properties, mentioned above. Already some groups have 
achieved excellent results in different areas tissue engineering in pharmacological application, since 
the release of the drug to optical equipment. To meet the various requirements of different 
applications, researchers still strive to extend the capabilities of fibroin from hydrophobic material 
such as hydrophilic material, by filaments films, sheets, and scaffolding. Interesting developments 
in study of silk have improved the hydrophilic ability and hydrophobic and mechanical rigidity and 
depending on the requirements. However, the degradation is a serious obstacle for its applications in 
vivo and in vitro even if they are been proposed a series of changes in its synthesis or with the 
addition of enzymes to promote cell adhesion. Some studies, where is evaluated the inflammatory 
response in vitro and after inoculation of human MSC in vivo rat. The in vitro response to silk 
fibroin was similar to response to collagen and to the tissue culture in bi-dimensional. In vivo, silk 
showed a lower inflammatory response when compared to collagen. The inflammatory potential of 
the silk fibroin was evaluated, also, in vitro in macrophages with percentages of synthesis of tumor 
necrosis factor alpha (TNF-α), a cytokine indicative of an inflammatory response, at levels equal to 
that of the tissue culture on plastic [151]. The fields of application of fibroin-based materials are 
several such as bone, cartilage, tendons, and skin [152]. In recent times is demonstrated that porous 
scaffolds in fibroin can be used to cultures of chondrocytes 3D, where the cells able to adhere to 
biomaterial structure using integrin subunits α5, β1, and β3 [111]. Alternative to natural 
biomaterials are synthetic polymers, widely used by over twenty years in surgical sutures. However, 
synthetic polymers current don't possess a surface chemistry able to consent cellular development in 
vivo, even if several are their advantages in their use, indeed, synthesized to ensure a wide range of 
mechanical and degradative properties. Some of these synthetic polymers used in tissue engineering 
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are briefly described.                              
Poly lactic acid (PLA) is a biodegradable polyester produced by the poly-condensation of lactic 
acid, amonomeric precursor obtained from renewable resources. Lactic acid is a chiral molecule 
available in stereoisomers forms L and D. L-lactic acid is in metabolism of all animals and 
microorganism, is a non-toxic degradation product. The Pla has showed excellent results in terms of 
biocompatibility and biodegradability such as to be used with excellent results in three-dimensional 
scaffold for the transplantation of cell in vivo [153].       
Poly-glycolic acid (PGA) is highly crystalline with high melting point and low solubility in organic 
solvents. In recent times, a research aimed has studied the improvement of properties with positive 
results in preparation of copolymers more hydrophilic compared to PLA.      
Poly-e-caprolactone (PCL), an aliphatic polyester biocompatible and bioresorbable, used in 
synthesis of pharmaceutical products. It shows a low melting point of about 60°, degraded by 
hydrolysis of ester linkages in physiological conditions (for example in the human body), getting a 
lot of attention in use of scaffolds in vivo[154].                              
Poly ethylene glycol (PEG), also known as polyethylene oxide (PEO), has low immune response 
after implantation. Additionally, it is showed that this polymer is useful to seal cellular membranes 
after injury, making it useful for limiting cell death. Hydrophilic PEG hydrogels can be made 
through a variety of cross-linking schemes to create scaffolds with varying rates of degradation. 
Further, procedures chemistries, have changed in these gels to add sites for cell adhesion or (ECM), 
molecules that allow cells to infiltrate into these scaffolds, extending their potential applications 
[116]. 
 
10.1 Methods used for scaffolds design 
Several techniques have been developed for the synthesis of polymeric matrices with synthetic and 
natural materials in porous structures. An overview of these different protocols, include: 
Electrospinning, solvent-casting, particulate-leaching, gas foaming, fiber meshes/fiber bonding, 
phase separation, melt molding, emulsion freeze-drying, solution casting and freeze drying [155]. 
Electrospinning is a technique for fabrication of nano-fibrose scaffolds. Various synthetic and 
natural polymers are produced with this technique, with fibers of diameters variable by nano to 
micrometer. They are characterized by a high surface to volume ratio and offer wide area in relation 
to the cellular substrate for cell attachment. In this technique, polymers are dissolved into a proper 
solvent or melted before being subjected to a very high voltage to overcome the surface tension and 
viscoelastic forces, able to forming different fibers (50 nm-30 mM) with high morphologic 
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similarity to the extracellular matrix of natural tissue and effective mechanical properties. These 
nanofibrous scaffolds can be utilized to provide a environment for cell attachment, migration, 
proliferation and differentiation, when compared with traditional scaffolds [156]. In general, the 
process of electrospinning is characterized by factors different, such as polymer molecular weight, 
viscosity, surface tension, conductivity, and process parameters, such as flow rate, electric potential, 
distance between capillary and etc. The intended use of  products of Electrospinning can be used to 
create thin films coated with biocompatible or with surface structures that have specific 
architectures that allow the deposited on implantable area. One of the major materials obtained from 
this technique is the collagen, organized nanofibers characterized by a wide range of distribution of 
the pore size, high porosity, excellent mechanical strength and high surface area in volume ratios, 
favorable parameters for cellular activity. The Freeze-drying, is a of the fabrication technologies for 
polymers, based on particulate-leaching techniques, heat compression, and extrusion. However, the 
harsh operating conditions of these processes may limit the incorporation of bioactive proteins and 
cells, indeed, amounts of the chemical solvents required to production, can cause toxicity in vivo. 
This method, leading to formation of ice crystals that can sublimate from the polymer, creating a 
catteristica micro-architecture. Since the growth direction and the size of ice crystals are functional 
of temperature gradient, different structures are produced with porosity linear, radial, and/or random 
[157]. On the other hand, the pore size can be controlled by the freezing rate and pH in fast freezing 
rate that produces smaller pores. 
 
 
11. Foreign body reaction to biomaterials 
As indicated in the review of 2012 by Bryers et al., the device biomaterials market consist of $ 
250B in 2014 where millions of humans have implanted medical devices with the objective improve 
the quality of life. The device failure or any complication  remain high, indeed, many devices that 
could impact medical practice do not work at all or fail early [158]. It has been estimated that in the 
United States at least 20 million people have implanted a device consisting of biomaterial. The 
possible problems to  success of a biomaterial implant is strongly associated with acute infections 
which can have disastrous consequences for function of device implanted. Although the risk of 
implant-associated infections is reduced (1-7%), these infections occur with high morbidity, to 
which are added to high costs for health care and prolonged use of antibiotics. The foreign body 
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reaction (FBR), also known as the host response vs to implanted biomaterials, defines the activity of 
complex series of immune modulators that are released in circulation in site implantation, including 
various types of cells, soluble mediators, and specific cellular interactions. The obstacles to 
successful implantation are mainly two; first is fibrotic encapsulation of the device (for example, 
the glucose sensor system) and the second the increase in release of enzymes and reactive 
intermediaries from activated cells capable of degrading the biomaterials[159]. The reactions from 
the host system vs biomaterials include specifically, interactions blood-material, the formation of 
provisional matrix, acute and chronic inflammatory conditions, development of granulation tissue, 
foreign body reaction, synthesis fibrotic tissue and development of fibrous capsule surrounding the 
implant. In the early stages of implant, the biomaterial is in contact with blood stream, a layer of 
proteins of the circle linked to the surface of the material, among these blood proteins included, 
such as fibrinogen (FG), fibronectin and vitronectin, opsonins such as immunoglobulin G (IgG) and 
C3b fragment of activated complement [158].           
Following the interactions blood/material and the formation of a provisional matrix, after the onset 
of an inflammatory state of acute and chronic type occurs in a sequential manner. Neutrophils 
(polymorphonuclear leukocytes, PMN) characterize the acute inflammatory response, indeed, mast 
cell degranulation with histamine release and absorption of fibrinogen is noted to mediate acute 
inflammatory responses against  implanted biomaterials [160]. In these phases, the release of 
interleukin-4 (IL-4) and interleukin-13 (IL-13) from mast cells, plays an important role in defining 
the size and the degree of subsequent development of the foreign body reaction [161]. The 
histamine is a fundamental regulator for the inflammatory responses and the recall of phagocytes, 
which in turn are in contact with implant surface supported by the action of fibrinogen. It is 
confirmed that receptor antagonists for histamine H1 and H2, significantly reduce the recruitment of 
monocytes/macrophages and neutrophils on surface of biomaterial. The acute inflammatory 
response against the biomaterial results in a short amount of time, in relation to the type of damage 
and the anatomical site of implant, usually resolves quickly, usually less than a week, depending on 
the extent of the damage in implantation site. Unlike the presence of mononuclear cells, including 
lymphocytes and plasma cells, identified the onset of chronic inflammation that is usually short-
lived, limited to site of implantation. The persistence of inflammatory state acute  indicate the 
presence of infection in which it detects the synthesis of granulation tissue with the presence of 
macrophages, the infiltration of fibroblasts, and neovascularization. The granulation tissue, the 
precursor of fibrous capsule, is  composed of layers of monocytes, macrophages and foreign body 
giant cells that separate the implant from the microenvironment in which it was fixed [162].   
The mechanisms that lead, biomaterials inert and non-toxic, to recall the accumulation of 
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inflammatory cells requires the activation of process such as  the chemotaxis of leukocytes that they 
move through the towards the implant and across the endothelium. This process is supported by 
several types of molecular signals that acting in the implantation site, including chemoattractants for 
initial recruitment of inflammatory cells. In the early stages of the system is initially records the 
presence of small molecules such as ATP, uric acid, and bioactive lipids that are leaked from the 
damaged cells. Also activated platelets release several growth factors, to which is added  the release 
various products of activated mast cells including histamine, proteoglycans, proteases and cytokines 
such as tumor necrosis factor-α (TNF-α) and interleukin-16 (IL-16). Within these phases the mast 
cells are able to favoring the synthesis and  the release of various other cytokines and chemokines, 
such as GM-CSF, IL-4, IL-6, IL-10, IL-13, MIP-α, and (MCP-1) macrophage inflammatory protein  
monocyte chemotactic protein [158]. One of aspects that stimulates the adhesion of macrophages to 
the biomaterial is the the interaction with integrin, the binding protein, which is assumed to 
provides intracellular signals that modulate the action of macrophages. Due to the action of 
podosomes, adhesion structures of macrophages with β2 integrins, useful for the initial adhesion of 
monocytes. FAK, focal adhesion kinase, of the Src family, becomes active after the interaction with 
integrins and it is responsible for regulating cytoskeleton dynamics of macrophages and of the 
assembly and disassembly of focal adhesions. A series of events are planned that finely regulate 
cell-cell fusion to the biomaterial where adherent macrophages merge to form foreign body giant 
cells. Foreign body giant cells show an antigenic phenotype similar to monocytes and macrophages. 
The adhesion of macrophages and foreign body giant cells to the surfaces of biomaterials creates a 
microenvironment between the cell membrane and the surface of the biomaterial. In a process 
described by Henson as frustrated phagocytosis, in which macrophages and foreign body giant cells 
release mediators such as reactive oxygen molecules (ROI oxygen free radicals), degradative 
enzymes in cell membrane and the biomaterial surface, acting as mediators of degradation [162]. 
Lymphocytes are an other important cellular immune population, present in implantation site during 
the inflammatory response The response of lymphocytes to biomaterials was not entirely studied in 
where many sides are still by understanding. The lymphocytes influence the behavior of 
macrophages to surfaces of biomaterials in vitro, they calling the monocytes from circulation, 
supporting adhesion, fusion and activation of degradative stage of macrophages. IFN-γ, IL-4 and 
IL-13 are other molecules secreted by lymphocyte cells that modulate the action of macrophages. 
For example, IFN-γ is known to activate macrophages promoting a pro-inflammatory state that is 
reflected in the ability to upregulation of presenting the antigen, and to favor the phagocytosis. In 
contrast IL-4 and IL-13 promote a response downregulatory which is indicated by an increased 
production of anti-inflammatory molecules such as  IL-8 [163]. 
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12. The use of biomaterial scaffold and his 
properties in cardiac repair  
Karan et al point out a set of guidelines that cover both the macromolecular appearance that 
micromolecular. In fact the planning of a appropriate biomolecular support for cardiac repair must 
be biocompatible to the needs to respecting the size of the heart, physical properties and 
topography, general parameters that must be taken into account in the synthesis of the scaffold to be 
used on the ischemic heart tissue [127]. Also the size of the scaffold and its consistency are 
carefully taken into account, because for the biomaterial is indicated a porous texture and 
sufficiently thin. If it is less than 0.5 mm allows adequate oxygenation and nutrition within the 
scaffold structure-cell. Furthermore, the microstructured and  nanostructured particles that make up 
the architecture of the scaffold must to possess small size enough to be easily implanted in the 
myocardium, making it possible also repeated inocula in well-defined areas with  use of mini-
invasive surgical techniques such as to injection catheter, with the use of echocardiography or 
fluoroscopy [164]. Recently, Al Kindi et al. emphasize the importance of the size scaffold for 
injection intra - myocardial where it has been reported an increase between 10 mm to 400 mm, the 
size of microspheres of alginate- poly-L-lysine-alginate was observed a four-fold increase in the 
retention rate of cells [ 165]. Topography, charge, roughness, hydrophilicity and hydrophobicity are 
also of great importance for the purposes of cell therapy. The hydrophobic and hydrophilic property  
play an important role in the kinetics of  protein adsorption,regulating the native conformation of 
the protein and the dependent cellular functions in the new tissue. When biomaterials are exposed to 
biological microenvironments, ECM proteins and molecules are non- specifically adsorbed on the 
surface of the scaffold. An intriguing study, using in vivo models of rat, showed that the hydrophilic 
charge on substrate surface can influence apoptosis after the increase on surface of the scaffold with 
a anionic charge and hydrophilic compared to hydrophobic surfaces of the cells. Indeed, the 
surfaces hydrophilic and anionic have a reduced percentage of adhesion and increase the number of 
apoptotic cells [166]. A growing number of works show the elastic characteristics how another 
important parameter. Most biomaterials used for cardiac cell therapy are developed to improve the 
conservation of inoculated cells and their consequential survival but as regards the contractile 
function of the heart, the scaffold must be able to respond with a certain degree of flexibility in a 
manner synchronous contraction of the myocardium, transferring mechanical stimuli but also in the 
infarcted microenvironment, especially to the cells of the differentiation process, providing stimulus 
for the proper development of the contractile phenotype. The complex cell-scaffold indirectly 
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interacts through their integrin receptors localized on the cell surface, able to regulate the activity of 
the cardiac cell by automatism called mechano-transduction [167]. The rigidity may be another 
phenomenon strongly connected to the cell behavior and their mechanical load. Indeed, cardiac 
cells, smooth muscle cells and endothelial cells of blood vessels are subject to strong and 
continuous mechanical stress. Cellular responses to the loads depend on the load conditions that are 
subject to multiple factors such as magnitude, duration and frequency of the load, but also by 
proteins of the surrounding matrix, as well as soluble factors. Some studies have also suggested that 
the orientation of the neonatal rat cardiomyocytes contractility and promotes stability of contractile 
fibres [127]. Therefore, the recent advances in the field of tissue engineering have popularized the 
concept of cell stem/progenitor for using in the useful synthesis biomatrices for tissue regeneration 
in situ. The process described before, joined to new generation of coated biomaterials with bioactive 
molecules to extended release, could be able to unlock the replicative processes of differentiation in 
complicated tissues such as hatt cardiac. In turn, this could lead promote the recruitment of 
stem/progenitor cells to the damaged area, acting on the processes of cell differentiation and 



















Principal purpose of regenerative medicine for the cardiac tissue is to find the best way to inoculate 
stem cells in a specific myocardial area damage, improving their homing, integration and survival. 
To achieve this goal, the field of biomaterials is important to bypass this obstacles, modulating the 
environment for implanted cells and enhance CSC function in the heart. Biomaterials can mimic or 
include naturally occurring extracellular matrix and instruct stem cell function in different ways: 
promoting angiogenesis, enhancing stem cell engraftment and differentiation, and accelerating 
electromechanical integration of transplanted cells. The aim of this thesis was to assess whether the 
properties of three-dimensional polymer matrices in synthetic biomaterial such as polylactic acid 
and in natural origin as silk fibroin, if and how influence differentiative process of stem cells  
cardiac c-kit +. Another point considered was been the evaluation of expression of cardiac markers 
and sarcomeric proteins of cells isolated, inoculated in different types of scaffold and maintained in 
colture for 21gg in vitro and analyzed in RT-PCR and Real-time quantitative RT–PCR analysis. 
Also it was analyzed the immunogenicity of the scaffold when implanted in the dorsal subcutaneous 
region of nude mice, nude rats and SCID mice in order a possible use in vivo in the cardiac 
regeneration. These experiments showed a myocardial-like differentiation, in which the CSCs 
acquired a muscle-like shape, with the formation of initial intercalated disks, and a striated-like 
myofilament organization. In results shown below highlights evidence of an higher degree of 
differentiation using 3D scaffold for CSCs c-Kit+ that can be induced to differentiate definitely into 
cardiomyocytes thanks to three-dimensional culture of the scaffold, where is possible an 


























1. P(d,l)LA scaffold microfabrication  
Becton Dickinson (BD) three-dimensional Open-pore Poly-lactic Acid (OPLA)® scaffold. The 3D 
OPLA® scaffold is a synthetic polymer synthesized from D, D-L, L polylactic acid. 
2. P(d,l)LA scaffold (Trento) 
Poly(d,l) Lactic Acid (P(d,l)LA) scaffold were produced by salt leaching, using a porous agent 
between 150 and 224 µm. The polymer was dissolved in dichloromethane/dimethylformamide 
solvent (70:30 v/v) and then mixed with a sufficient amount of sodium chloride salt. The resultant 
mixture was dried under chemical hood and, in order to eliminate the residual solvent and salt, 
subjected to continuous washes into water for three days. Finally the sponges were frozen at -20°C 
and lyophilized for 2 days. The size of the porogen particles will affect the size of the scaffold 
pores, while the polymer to porogen ratio is directly correlated to the amount of porosity of the final 
structure. After the polymer solution has been cast the solvent is allowed to fully evaporate. Then 
the composite structure in the mold is immersed in a bath of a water for dissolving the porogen. 
Once the porogen has been fully dissolved a porous structure is obtained. 
2.1 Fibroin–water solution 
Bombyx mori cocoons (kindly provided by Socio Lario, Cassina Rizzardi, Como, Italy) were boiled 
for 1.5 h in an aqueous solution containing 1.1 g/l Na2CO3 (10 g silk/l solution) and then for another 
1.5 h in bath of water containing 0.4 g/l Na2CO3. The cocoons were rinsed thoroughly with distilled 
warm water to extract the glue-like sericin proteins and finally air-dried. The fibroin–water solution 
was prepared by dissolving fibroin in an aqueous solution containing 9.3M LiBr (10% w/v; Fluka 
Chemical) at 65 C for 2 h, followed by dialysis (for 3 days) against distilled water with a 3500Da 
MWCO membrane (Slyde-A-Lyzer, Pierce) to eliminate the salt. The resulting solution was 
concentrated by dialysing against a PEG–water solution (25%w/v) for 5 h and filtered through a 
160–250mm filter (Duran Group). The final concentration of silk fibroin in the aqueous solution 
was approximately 15% w/v, as determined using a NanoDropND-1000 Spectrophotometer (A280). 
2.2 Freeze-dried sponges 
3D porous fibroin scaffolds were prepared using a freezedrying technique with different parameters 
to obtain different pore sizes and orientations. The aqueous fibroin solution was diluted to 5%, 
poured into polystyrene Petri dishes, frozen at –80 C and freeze-dried (sample RP). Spongeswith an 
orientated structurewere obtained using the 5% fibroin solution, but the Petri dish was positioned 
vertically to induce a temperature gradient (sample O). All obtained samples were stabilized by 
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treating with a methanol:water solution (80:20) for 10min, rinsed with distilled water to eliminate 
the solvent and freeze-dried again. 
2.3 Electrospun nets 
The aqueous fibroin solution was frozen at –20 °C, lyophilised at –50 °C and stored in a desiccator 
until use. The freeze-dried fibroin was dissolved in formic acid (98–99%) at 15% w/v. A 3ml 
syringe with a metal needle was filled with the solution and mounted in a programmable syringe 
pump (Model 11 Plus, Harvard Apparatus), providing a constant flow rate of 0.002 ml/min. A 
positive voltage (15 or 20 kV) was applied to the solution by the needle, while a rotational mandrel, 
which was covered with aluminium, was connected to the ground electrode. The deposition was 
performed at room temperature at constant rotational speed (3250 rpm) for 8 h. The resulting non-
woven nets were stabilized in methanol/ H2O (80/20 v/v) for 10 min and washed in distilled water 
for 2 days to remove the residual solvent (sample F). 
2.4 Field-emission scanning electron microscopy (FE-SEM) 
All scaffolds were examined with a field-emission scanning electron microscope (FE-SEM; Supra 
40, Zeiss). Samples were observed after coating with gold in a reduced argon atmosphere. SEM 
photos, fibre diameters of the nanofibrous membranes and pore sizes of the sponges were analysed 
using the image visualization software ImageJ, which was developed by National Institutes of 
Health (http://rsb.info.nih.gov/). 
 
2.5 Water content 
The water uptake of the three different sponges was measured by weighing the samples in the dry 
state and then in the wet state. Water was added one drop at a time onto the surface of the sample, 










3. Cell isolation and purification 
In contrast with previous studies, in which cells were isolated by antibody-mediated cell sorting, our 
c-Kit+ cells were isolated for their proliferative potential and not for the expression of particular 
surface markers. Mature (150–200 gr) female Sprague–Dawley rats were anesthetized with 2% 
halothane in O2 and their hearts were excised away from the chests, still beating. Each excised heart 
was put (HBSS) with 50 U/ml collagenase II (Gibco; Invitrogen Corp., Carlsbad, CA), and 3 
mmol/L CaCl2, to avoid blood coagulation into the coronary vessels. Under a laminar flow hood, 
the atria were separated from the ventricles and the last ones were cut into four pieces, and these 
pieces were put into 20 ml of HBSS with 50 U/ml collagenase II and 1.25 mmol/L CaCl2 1 
heart/tube. After 10 min of incubation at 37°C in a rotating dry incubator, the solution was collected 
and pieces left on the bottom of the Falcon tube. Isolated cells were removed from the collagenase 
solution by centrifugation and put into fresh M-199 medium (BD Biosciences, Franklyn Lakes, NJ) 
supplemented with 20% fetal bovine serum (FBS; Biolife Italiana S.r.l., Milano, Italy), 3mg/ml 
fungizone, 300 mg/nml streptomycin, and 300 U/ml penicillin. Another 20 ml HBSS with 50 U/ml 
collagenase II and 1.25 mmol/L CaCl2 were put in the Falcon tube with the four pieces, and one 10- 
min incubation started again. Hence, we performed repeated cycles of 10-min incubation followed 
by 5-min centrifugation; five to six cycles were considered a fraction, and three fractions were 
obtained in 4 h. The second one, got after the second five centrifugations, was filtrated with nylon 
net filters (Millipore) whose diameter was 80 μm .This method of tissue digestion allowed a rapid 
recovery of cells, a higher yield and a shorter exposure of the isolated cells to the collagenase 
solution. All fractions of one heart were placed into 25 cm2 flasks (Braun Medical, Inc., Bethlem, 
PA, http://www.bbraunusa.com) with fresh M-199 medium supplemented with 20% FBS and 
cultured for were obtained from only the 2nd and 3rd fractions; a good yield was 500–600,000 
cells/heart within 1 week. The quality of plastic-ware greatly affected the growth potential and the 
selection of these cells. In fact, in Braun culture flasks c-Kit POS cells scarcely attached, showed a 
different morphology compared to cardiac fibroblasts (as viewed with phase contrast light 
microscopy) and tended to live in suspension. In particular, when cell suspension collected from 
tissue digestion was placed in Braun flasks, after 4–5 days, many fibroblasts adhered to the flask 
and a few groups of cells preferred to live on the fibroblast layer or in suspension. Braun-flask 
adherent cells were identified as cardiac fibroblasts. They were negative for c-Kit, CD34, nestin, 
GATA-4 and positive for vimentin (Fig. 2). Cells collected from the suspension and obtained by a 
light trypsinization were plated onto BD or Corning flasks (BD Biosciences; Corning Incorporated, 
Corning, NY), where they attached firmly and grew quickly. Poly-D-lysine 5mg/ml (Sigma–
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Aldrich, St. Louis, MO) is a good substrate for improving adhesion. In this manner, even without a 
flow cytometer, we isolated a population of cells that was 80–94% positive for c-Kit. 
4. Cell seeding in 2D and 3D cultures 
For bi-dimensional cultures, the plasticware was coated with 0.1mg/ml poly-D-lysine in PBS. The 
cells were plated in 75 cm2 flasks, grown in presence of M-199 (BD Biosciences, Franklyn Lakes, 
NJ, USA) grow medium, supplemented with 20% FBS (Biolife Italiana), antibiotic-antimycotic 
solution 1x (Lonza), L-glutamine 1x (Gibco) for 21 days, as previously described [58]. 
For three-dimensional cultures, cells were cultured into the Open-pore Polylactic Acid (OPLA) 
scaffolds (BD Biosciences) and into customized Poly(d,l) Lactic Acid (P(d,l)LA) composite 
scaffolds: P(d,l)LA-N, P(d,l)LA-U (synthesized with a porosity agent less than 224 μm), Silk 
fibroin random porosity (RP) (synthesized with a porosity agent less than 28-85µm), Fibroin 
electrospin nets (F) (synthesized with  Fiber diameter 332±74 nm) Scaffold with fibroin porous 
partially oriented (O) (synthesized with a porosity agent less than 200-400 nm) kindly provided by 
Biotech Laboratories (University of Trento). Before cell seeding, customized scaffolds were 
sterilized with 96% ethanol for 1 h. Thereafter, scaffolds were equilibrated with M-199 medium 
supplemented with 20% FBS, and air dried. A mix of CSCs collagen type I rat tail (BD 
Biosciences) diluted 1:8 in M-199 grow medium was prepared on ice. Small pieces of scaffolds 
were embedded with cells and collagen mix and kept for half-hour at 37°C inside inserts for 24-well 
plates (BD Biosciences); each insert contained 4x105cells. Then scaffolds were layered with 
collagen I in M-199 (dilution 1:8) and kept at 37°C for 3 hours in order to allow the solidification of 
collagen I. Afterwards, inserts were filled with growth medium and left in incubator for 21 days 
changing medium every two days. After incubation, the 3D cultures were fixed with acetone:-
methanol:water (2:2:1), for immunofluorescence analysis, or 2.5% glutaraldehyde (Electron 
Microscopy Sciences, Hatfield, PA, USA) in 100mM sodium cacodylate buffer (Sigma-Aldrich) for 
transmission electron microscopy (TEM) to enhance visualization of the cell membrane in 3D 
cultures, as previously described [168]. 
5. Flow cytometry analysis 
After detaching from flasks, cells were counted and placed into FACS tubes (2x105 cells/sample). 
Initially, cells were washed in PBS and then fixed in cold methanol on ice for 20 minutes. After 
washing, cells were blocked with incubation buffer (9 PBS : 1 M-199 + 10% FBS) at room 
temperature for 15 minutes. Cells were incubated with primary antibodies diluted 1:200 in 
incubation buffer for 45 minutes at room temperature anti-c-Kit, [KAP-TK005], (Stressgen 
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Bioreagents, Ann Arbor, MI, USA); anti-Ly-6A/E (Sca-1), clone E13-161.7 (Santa Cruz 
Biotechnology, Inc); anti-MDR1, SC-71557 (Santa Cruz Biotechnology, Inc), rinsed twice in PBS 
and incubated with secondary antibodies diluted 1:200 in incubation buffer for 45 minutes at room 
temperature in the dark. After two washes in PBS, cells were analyzed with a FACSCalibur Flow 
Cytometer (BD Biosciences). The unstained sample was used to calibrate the analysis. 
6. Immunofluorescence on CSCs 
Cells cultured on poly-D-lysin (Sigma–Aldrich) coated chamber slides were fixed firstly with 4% 
PFA for 15 min and after with ice-cold methanol for 30 min. Antigen retrieval with 10 mM citrate 
buffer (pH 6.0) with 0.05% Tween 20 for 10min. After incubation with 5% Bovine Serum Albumin 
(Sigma–Aldrich) for 30 min, cells were incubated with primary antibodies, diluted 1:50 in PBS, 
overnight at 4°C [anti-c-Kit, KAP-TK005, (Stressgen Bioreagents, Ann Arbor, MI, USA); anti-Ly-
6A/E (Sca-1), clone E13-161.7 (Santa Cruz Biotechnology, Inc); anti-MDR1, SC-71557 (Santa 
Cruz Biotechnology, Inc)]. Primary antibody was detected with: 1:50, FITC-conjugated anti-goat 
secondary antibody (Sigma–Aldrich). Nuclei were stained 10 minutes with 10 μg/ml Hoechst33342 
staining in PBS (Invitrogen Corp., Carlsbad, CA). Cells were observed using Leica CTR5000 
fluorescent microscope. 
 
7. Selection of positive cells Sca-1 
For isolation of Sca-1 positive cells was used the Do-It-Yourself kits of EasySep (Stem Cell 
Technology cod. 18098). It consists of a cocktail of selection previously prepared, a mixture of 
magnetic nanoparticles and a magnet (RoboSep®). In this mix there the antibody is anti-Ly-6A/E 
(Sca-1), clone E13-161.7 (Santa Cruz Biotechnology, Inc), cell specific object of the search. The 
antibody and mix together, form the tetrameric Antibody Complexes (TAC), bi-specific, in fact the 
one hand recognizes the surface antigen of the cells (in this case, Sca-1) and the other magnetic 
nanoparticles, as it recognizes the residues of dextran by which they are covered. The preparation of 
the cocktail were taken 75μl of antibody Sca-1 (corresponding to 15μg of antibody, from the  initial 
concentration of 200μg/ml). In test tube were added 100 µL of solution A and solution B was 
extensively mixed and incubated at 37°C overnight. The volume of the vial was brought to 1 ml by 
adding sterile PBS (phosphate buffered saline). The cells are detached from the flask by 
trypsinization (0.05% trypsin and 0.02% EDTA) (Trypsin -EDTA solution 10x , Sigma-Aldrich) 
and resuspended in the recommended medium (composed of 49 ml of PBS, 2% FBS, EDTA), so as 
to add 10μl of cocktails previously prepared per ml of cells. The mix composed was left at room 
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temperature for 15 minutes. At this point, magnetic nanoparticles were added (50μl of particles per 
ml of cells), mixed to the solution and left at room temperature for 10 min. The entire solution was 
resuspended in final volume of 2.5 ml, adding the medium recommended. Finally, the tube was 
placed in the magnet RoboSep® and incubated for 5 min. Subsequently for manual inversion, the 
cells are separated due to the link of magnetic nanoparticles conjugated with anti Sca-1. The cells 
remain at the bottom of the tube, isolated from the supernatant. The magnet was removed and the 
tube were added 2.5 ml of medium recommended and mixed, and then be put back into the magnet, 
left 5 minutes and invert manually. The above procedure was repeated 2 more times so you have a 
complete selection of Sca-1 positive cells . 
8. Tumorigenicity tests: Tumorigenicity of  CSC was assessed in vitro and in 
vivo. 
In vitro  
CSCs, the cell line VERO (negative control) and the cell line Hep-2 (positive control) were cultured 
in vitro into three different 75cm2 flasks (BD Biosciences). Later, each cell culture (1x105 cells) 
was inoculated in six-well plates containing the solid medium (MEM plus Agar Noble, BD 
Bioscience) and incubated at 37°C. They were observed at inverted microscope for 3 weeks. The 
number of colony forming units (CFU) were counted and compared to the control (Hep-2). 
In vivo 
Cardiac progenitor, VERO and Hep-2 cells were inoculated in vivo by intracutaneous injection. 
Every cell type was injected in 10 Nude mice. Animals have been observed for 21 days and any 
new-formation of nodules in the injection area was check. The size and weight of the neoplasia 
were measured to evaluate the growth after 21 days. The test was considered valid if at least 9 mice 
inoculated with the positive control cells (Hep-2) produced a neoplasia. 
9. Animal models 
Constructs of CSC and collagen I gel were injected into 5-week old athymic Nude-Foxn1nu (Nude) 
mice, C.B-17/IcrHan®Hsd-Prkdcscid (SCID) mice and athymic Hsd:RH-Foxn1rnu (Nude) rats 
(Harlan Laboratories Inc., Indianapolis, USA). All experimental protocols used in this study were 
approved by the Animal Care and Use Committee of “Ministero della Sanità”. 
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10. Three dimensional construct microinjection 
Constructs were injected with a 0.5-mm trocar in the dorsal subcutaneous region of Nude mice, 
SCID mice, and Nude rats,  one injection per animal. The animals were kept in captivity for 45 
days. After that period, they were sacrificed by displacement of the first cervical vertebra, and 
nodules were excised, fixed in a solution of acetone:methanol:water (2:2:1 v/v) and embedded in 
paraffin. Finally, the embedded nodules were cut into 5-µm sections and stained with 
haematoxylin/eosin or Masson’s trichrome staining or treated for immunohistochemistry or 
fluorescence in situ hybridization (FISH) analysis. 
11. Transmission electron microscopy 
Three-dimensional cultures were grown in M-199 medium (Life Technologies) supplemented with 
20% FBS (Life Technologies) for 21 days and then fixed twice. In the first step, scaffolds were 
fixed with 2.5% glutaraldehyde (Electron Microscopy Sciences), in 100 mM sodium cacodylate 
(Life Technologies) buffer (pH 7.4) for 30 min and rinsed 3 times with 100 Mm sodium cacodylate 
buffer. A second step of fixation was performed with 2% OsO4 (Electron Microscopy Sciences) in 
100mM sodium cacodylate buffer. After fixation, samples were rinsed twice with 100 mM sodium 
cacodylate buffer (pH 7.4), and dehydrated with ethanol (25%, 50%,70%,95% and 100%). After 
dehydration scaffolds were embedded into EPON resin (Electron Microscopy Sciences) with 
passages of 1:3 of resin/70% ethanol, 3:1 resin/70% ethanol for 2 h, pure resin overnight, pure resin 
with 0.1 ml DMP-30 (EMS) for 3h before inclusion and for 65°C at 48 h. Semi-thin sections were 
prepared and stained with Methylene Blue (Sigma-Aldrich). 
12. Haematoxylin/eosin staining  
To assess the aspect of the constructs, paraffin sections were stained with haematoxylin and eosin 
(H&E). Scaffolds with cells were fixed in a solution of acetone, methanol and water (2:2:1) for 12h, 
washed in tap water and dehydrated with ethanol at 30%, 50%, 70%, 95% and 100% v/v. After 
dehydration, the tissue pieces were placed in xylol for 1 h and embedded in paraffin. The paraffin-
embedded tissue samples were cut into 5 mm sections. The sections were deparaffinized with 
xylene for 10 min and hydrated with a decreasing ethanol gradient. They were stained with 
haematoxylin for 4 min (Merck KGaA, Darmstadt, Germany), blocked for 15 min in tap water, 
treated with eosin (Merck KGaA) for 1 min and rinsed in water. The sections were dehydrated and 
mounted using Canada balsam (Panreac Química S.L.U., Barcelona, Spain). Images were captured 
using a Leica DM5000 microscope. 
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13. Masson’s trichrome staining 
The tissue sections were placed in distilled water and subsequently stained with hematoxylin ferric 
(Bio-Optica, Milan, Italy) for 10 minutes. Subsequently, without carrying out any washing, on the 
sections was placed picric acid (Bio-Optica, Milan, Italy), and left to act for 4 minutes. Were 
washed quickly in distilled water and place on them the solution ponceau (Bio-Optica, Milan) for 4 
minutes. Washed again in distilled water and incubated for 10 minutes with a solution of 
phosphomolybdic acid (Bio-Optica, Milan). Finally, the slides were drained, not washed, and 
stained with aniline blue (Bio-Optica, Milan, Italy) for 5 minutes. Washed in distilled water, rapidly 
dehydrated through ascending alcohols, passed in xylene and mounted with Canada balsam 
(Panreac Quimica SLU, Barcelona, Spain). The preparations were examined by optical microscope 
Leica DM5000. 
14. Immunofluorescence on scaffold section 
Scaffolds without cells were fixed in a solution of acetone, methanol and water (2:2:1) for 12h, 
washed in tap water and dehydrated with ethanol at 30%, 50%, 70%, 95% and 100% v/v. After 
dehydration, the tissue pieces were placed in xylol for 1 h and embedded in paraffin. The paraffin-
embedded tissue samples were cut into 5 mm sections. The sections were deparaffinized with 
xylene for 10 min and hydrated with a decreasing ethanol gradient. The section were incubated with 
primary antibodies diluted 1:100 overnight at 4°C with IL-4 (M-19, SC-1261), IL-13 (C-19, SC-
1292) and CD11b (p170, SC-6614), (Santa Cruz, CA). Bound primary antibody was detected with 
1:50, FITC-conjugated goat anti-rabbit secondary antibody (Sigma–Aldrich). TOTO®-3 (T3604, 
Life technologies) stain is a carbocyanine dimer with far-red fluorescence similar to Alexa Fluor® 
647 used as a nuclear counterstain. The sections were mounted using Fluoro Care Mountant 5 ml 
(Biocare medical, FP001G5) Images were captured using a ZEISS LSM710 Exciter Laser Scanning 
Confocal Microscope. 
15. Immunohistochemistry 
Immunohistochemistry was performed with a biotin-free technology using a specific probe to detect 
rabbit and goat antibodies followed by a horse radish peroxidase (HRP)-polymer, (MACH 1 Kit for 
rabbit antibodies, Biocare Medical, Concord, CA, USA) or alkaline phosphatase (AP)-polymer 
(Goat AP-polymer kit for goat antibodies, Biocare Medical). After deparaffination and rehydration, 
the tissue sections were incubated with a 3% hydrogen peroxide solution (Sigma–Aldrich) for 5 
min. After incubation with the protein blocking agent Background Sniper (Biocare Medical) for 15 
min, the tissue sections were incubated with the anti-CD3 antibody (rabbit polyclonal, AO452, 
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DAKO Denmarks A/S, Glostrup, Denmark) or IL-4 (SC-1261 Santa Cruz Biotechnology) diluted 
1:100 for 1 h. The linked primary antibody was detected using MACH 1 or Goat-AP kits 
respectively, according to manufacturer’s instructions. Biocare's Betazoid Diaminobenzidine 
(DAB) was used as a HRP substrate. Warp Red™ Chromogen  was used as AP substrate. The 
sections were then washed in tap water and counterstained with haematoxylin for 1 minute. 
VectaMount (Vector Laboratories Inc., Burlingame, CA, USA) was used as the mounting medium. 
16. Fluorescence in situ hybridization   
Paraffin embedded sections were kept at 37°C O.N. and then at 60°C for 10 minutes. The sections 
were deparaffinised in xylol at 60°C for 10 minutes, hydrated through a graded ethanol series, and 
immersed for 15 minutes in citrate buffer with 1% Tween 20 for heat-induced target retrieval. 
Slides were cooled to RT for 5 minutes and placed in PBS with 0.1% Tween (Sigma–Aldrich). To 
catalyse the degradation of RNA, the slides were treated with 10 μg/μl RNase at 37°C for 1 hour. 
FISH was performed on sections by hybridising with a 5’-3’ 6-carboxyfluorescein (FAM) labelled 
Custom LNA™ FISH Probe that recognises mouse centromeres but not rat centromeres (/5’-
FAM/ATTCGTTGGAAACGGGA /3’-FAM/ -Exiqon A/S, Vedbaek, Denmark). The LNA probe 
was used at a concentration of 6.4 pmol in hybridisation buffer (50% formamide, 2x saline-sodium 
citrate buffer-SSC, pH 7), and the slides were denatured at 75°C for 5 minutes, followed by 1 hour 
hybridisation at 60°C. The sections were washed three times with 0.1x SSC at the hybridisation 
temperature for 5 minutes and two times with 4x SSC with 0.05% Tween 20 at 37°C, followed by a 
wash in PBS at RT for 5 minutes. Nuclei were counterstained with a 1:1000 dilution of TOTO-3 
(Life Technologies) in PBS at RT. The sections were mounted using Vectashield (DAKO) for 
confocal analysis. Images were captured using a ZEISS LSM710 Exciter Laser Scanning Confocal 
Microscope. 
17. RNA extraction and RT-PCR 
CSCs were cultured into BD, P(d,l)LA scaffold or fibroin scaffolds inside inserts (2 x 105 
cells/insert; BD Biosciences) and allowed to grow and differentiate for 21 days in M-199 medium 
supplemented with 20% FBS in a cell culture incubator.  
Total RNA from cell grown for 21 days in bi-dimensional and three-dimensional cultures was 
purified by using ChargeSwitch® Total RNA Cell Kit (Life Technologies Europe BV Kwartsweg, 
Bleiswijk, Netherlands), whereas total amount of RNA from cardiac tissue was extracted using 
QuickPrep Total RNA Extraction Kit (GE Healthcare Bio-Sciences Corp., Piscataway, USA). RNA 
from both extractions was quantified by Qubit® RNA Assay Kits (Life Technologies). 5 ng total 
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RNA per reaction was reverse-transcribed using ImProm-II Reverse Transciptase Kit (Promega 
Corporation, Madison, Wisconsin, USA) and GoTaq Flexi DNA Polymerase (Promega 
Corporation) following manufacturer’s instructions. cDNA was amplified using primers listed in 
Table1. Beta-actin was used as a positive control. RT-PCR products were separated on 3% agarose 
gel and visualized with UV light. The gel was stained with SYBR Safe DNA gel stain (Life 
Technologies). ImageJ Free software (NIH, Bethesda, MD) (http://rsb.info.nih.gov/ij/) was used to 
obtain a numeric value for each band intensity (Mean intensity of color x Number of pixels). Values 
between 1 and 150,000 were considered +/-; values between 15,000 and 50,000 were considered +; 
values between 50,000 and 120,000 were considered ++; values between 120,000 and 200,000 were 
considered +++; 0 was considered – (Table 3). The gel was stained with SYBR SafeDNAgel stain 
(Life Technologies). PCR fragments purified using the Nucleospin PCR and Gel Clean-up Kit 
(Macherey-Nagel GmbH & Co. KG, Düren, Germany) were sequenced by the MWG Biotech 
Sequencing Service (Edersberg, Germany). Sequences were then analyzed with the BLASTn Web 
Tool on the NIH website (http://www. ncbi.nlm.nih.gov/BLAST/). All PCR-amplified fragments 
corresponded to the desired target. 
Table1.Primers used for semiquantitative reverse-transcription-polymerase chain reaction 
Primer Target Sequence    Forward Reverse 
Beta actin Actb NM_031144 5’-AGCCATGTACGTAGCCATCG-3’ 5’-CTCTGAGCTGTGGTGGTGAA-3’ 
Laminin Lamb3 NM_001100841.1 5’-TGTAGTTCTGCAGCCATTCG-3’ 5’-CATAGGGCTGGAAGCAAGAG-3’ 
Integrin alpha V Itgav_XM_003749496.1  5’-GCTGCCGTTGAGATAAGAGG-3’ 5’-TGCCTTGCTGAATGAACTTG-3’ 
Integrin alpha 6 Itga6 NM_0537251 5’-GGTGACTTCAAAGCCTGCTC-3’ 5’-AGCCAGATCAAAAACCAAGG-3’ 
Integrin alpha 7 Itga7 NM_030842 5’-ACCTGTGCACACCGATATGA-3’ 5’-GCAGAACCCAAATTGTTCGT-3’ 
Integrin Beta 1 Itgb1 NM_017022 5’-GAACAGCAAGGGTGAAGCTC-3’ 5’-CACAGTTGTCACGGCACTCT-3’ 
Fibronectin 1 Fn1 NM_019143 5’-GAAAGGCAACCAGCAGAGTC-3’ 5’-CTGGAGTCAAGCCAGACACA-3’ 
Ilk Ilk NM_133409 5’-AAGGTGCTGAAGGTTCGAGA-3’ 5’-CAGTGTGTGTATGAGGGTTGG-3’ 
Fak PtK2 NM_013081 5’-CGTGAAGCCTTTTCAAGGAG-3’ 5’-TCCATCCTCATCCGTTCTTC-3’ 
CgA Chga NM_021655.2 5’-GCCACCAATACCCAATCACC-3’ 5’-CTTTAGGCCCAGCCTTCTCT-3’ 
Collagen 1 α1 Col1a1 NM_RATC1A1PR 5’-GGGTGCTAGATCAGGAGCAG-3’ 5’-ATGCCCACTCCCTAACAGTG-3’ 
Vitronectin Vtn NM_019156 5’-ACCCTGATTATCCCCGAAAC-3’ 5’-CAAACACGGCTGACAGAGAA-3’ 
eNos NOS3 NM_021838.2 5’-TGACCCTCACCGATACAACA-3’ 5’-CTGGCCTTCTGCTCATTTTC -3’ 
Hsp90 HSP90ab1 NM_001004082 5’-GATTGACATCATCCCCAACC-3’ 5’-CTGCTCATCATCGTTGTGCT-3’ 
Trop T2 Tnnt2 NM_012676.1 5’-CGTGAGGAGGAGGAGAACAG-3’ 5’-CGGCCTCTAGGTTGTGGATA-3’ 
Myosin HC6  
Cardiac Muscle α 
Myh6 NM_017239.2 5’-CTGCTCAAGGGTCTGTGTCA-3’ 5’-CGAACATGTGGTGGTTGAAG-3’ 
Akt Akt2 NM_ 017093.1 5’-CAGCATCGGTTCTTCCTCAG-3’ 5’-AGAACTGGGGGAAGTGTGTG-3’ 
Calmodulin Calm1 NM_031969 5’-ACTGGGTCAGAACCCAACAG-3’ 5’-CTTGACCTGTCCGTCTCCAT-3’ 
Caveolin Cav3 NM_019155.2 5’-AGACCACTTTCACCGTCTCC-3’ 5’-GCTGATGCACTGGATCTCAA-3’    
CD73 Nt5e NM_021576 5’-AGAGCAAACCAGCGATGACT-3’ 5’-CATTTCTGAGGAGGGGATCA-3’ 
CD14 Cd14 NM_021744 5’-CTTGTTGCTGTTGCCTTTGA-3’ 5’-CGTGTCCACACGCTTTAGAA-3’ 




18. Real-time quantitative RT–PCR analysis 
Quantitative RT–PCR (qRT–PCR) analysis was performed using GoTaq qPCR Master Mix 
(Promega). mRNA levels were normalized to that of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), hypoxanthine phosphoribosyl transferase 1 (HPRT1), ribosomal protein S6 kinase (S6) 
and b-glucuronidase (GUSB). Changes in the transcript level were calculated using the – ΔΔCT 
method [20]. cDNA was amplified using the primers indicated in Table S2 (see Supporting 
information). cDNA was amplified using the StepOnePlus™ Real-Time PCR System (Life 
Technologies). PCR fragments purified using the Nucleospin PCR and Gel Clean-up Kit 
(Macherey-Nagel GmbH & Co. KG, Düren, Germany) were sequenced by the MWG Biotech 
Sequencing Service (Edersberg, Germany). Sequences were then analyzed with the BLASTn Web 
Tool on the NIH website (http://www.ncbi.nlm.nih.gov/BLAST/). All PCR-amplified fragments 




Table2. Primers used for Real-time quantitative RT–PCR analysis 
Primer Target Sequence Forward Reverse 
Ribosomal Protein S6 Rps6 NM_017160 5’-TCTTGTTACTCCCCGTGTC-3’ 5’-CAGCCTCCTCCTTGTTTTTC-3’ 
GADPH Gapdh-ps2 NG_028301 5’-GAAACCCATCACCATCTTCC-3’ 5’-TCCACGACATACTCAGCAC-3 
Hprt1 Hprt1 NM_012583 5’-TGTCATGAAGGAGATGGGAG-3’ 5’-ATCCAGCAGGTCAGCAAA-3’ 
Glucoronidase β Gusb NM_017015 5’-ACCACCCCTACCACCTATATC-3’ 5’-ATCCAGTAGTTCACCAGCCC-3’ 
Cardiac α Actin 1 Actc1 NM_019183 5’-TACCAGGATGTGTGACGACGAG-3’ 5’-ATCATCACCCGCAAAGCCAG-3’ 
Muscle Z-Line Capping 
Protein α3 Capza3 NM_017164 5’-ATGAGAAGCTCATGCACCAC-3’ 5’-TCAAAGAACCGGAAGTCACC-3’ 
Myosin-Binding 
Protein H Mybph NM_031813 5’-AGCCCAGCCCTTTTGATTC-3’ 5’-ACCTCCAACCGACAATCCAC-3’ 
Nebulette Nebl XM_225644 5’-GAAAGGCCTCTCCGATTATG-3’ 5’-TTACTCTGGTGCCTGTTGACC-3’ 
Telethonin-Like Titin cap protein XM_001081394 5’-TGTCAAGTGTCTGAGGAGAACC-3’ 5’-AGGTCTCATGCCTCTGTGTATC-3’ 
Titin Ttn XM_575155 5’-TGGCGAGTATACCTGCAAAG-3’ 5’-AGAAACTTGGCTGCCTTCC-3’ 
Cardiac Troponin I 
Type 3 Tnni3 NM_017144 5’-AGATTGCGAAGCAGGAGATG-3’ 5’-AGCCCATCCAACACCAAG-3’ 
Tropomodulin 1 Tmod1 NM_013044 5’-TCTCCCCCACAACACTTCTC-3’ 5’-CCATTTCCACTTTGTTGCCC-3’ 
Cardiac Troponin T 
Type 2 Tnnt2 NM_012676.1 5’-GCGGGCTGAACAGCAGCGTA-3’ 5’-TTCAGCCAGGCGGTTCTGCC-3’ 
Myosin HC7 Cardiac 






19. Preparation for TEM 
The 3D cultures were grown in M-199 medium (Life Technologies) supplemented with 20% FBS 
(Life Technologies) for 21 days and then fixed twice. In the first step, scaffolds were fixed with 
2.5% glutaraldehyde (Electron Microscopy Sciences) in 100mM sodium cacodylate buffer, pH 7.4 
(Life Technologies), for 30 min and rinsed three times with 100mM sodium cacodylate buffer. A 
second fixation step was performed with 2% OsO4 (Electron Microscopy Sciences) in 100mM 
sodium cacodylate buffer. After fixation, the samples were rinsed twice with 100mM sodium 
cacodylate buffer, pH 7.4, and dehydrated with an ethanol series (25%, 50%, 70%, 95% and 100%). 
After dehydration, the scaffolds were embedded in EPON resin (Electron Microscopy Sciences) 
with passages of 1:3 resin:70% ethanol for 2 h, 3:1 resin:70% ethanol for 2 h, pure resin overnight, 
pure resin with 0.1 ml DMP-30 for 3 h before inclusion and for 48 h at 65°C. Semi-thin sections 
were prepared and stained with methylene blue (Sigma-Aldrich) or used for immunohistochemistry. 
20. Immunohistochemistry on EPON semi-thin sections 
EPON-embedded TEM samples were cut into 1 mm semithin sections and dried over poly-D-lysin-
coated slides unstained. The slides were then treated with 10% sodium ethoxide for 6 min at room 
temperature under a laboratory chemical hood to dissolve the EPON resin. After two 5 min rinses in 
100% ethanol, the sections were rehydrated with an ethanol series (95%, 70%, 50%, 30%) and 
distilled water. After rehydration, the sections were rinsed in Tris buffer saline (TBS), pH 7.3, for 5 
min and heated in a microwave oven at 700W for 5 min in a hot unmasking sodium citrate buffer, 
pH 6. After 30 min at room temperature, the sections were rinsed twice for 5 min in TBS and 
endogenous peroxidase blocked, treating the slides with 3% H2O2 for 5 min. Then the sections were 
blocked with 3% BSA in TBS for 30 min and incubated for 1 h at room temperature with the 
antititin antibody (SC-8724, Santa Cruz Biotechnology; diluted 1:50 in 1% BSA in TBS). After two 
rinses in TBS, the sections were incubated with Goat Probe (GP613G, Goat AP-Polymer Kit, 
Biocare Medical LLC, Concord, CA, USA) for 15 min, rinsed twice in TBS and incubated with 
Goat Polymer AP (GAP628G, Goat AP-Polymer Kit, Biocare Medical) for 15min. After three 5 
min rinses in TBS, the sections were incubatedwith Warp Red™ chromogen (WR806 H, Biocare 
Medical) for 10 min and the reaction was stopped under tap water. The sections were then 
counterstained with haematoxylin for 30 min at 60°C; the reaction was stopped with tap water and 
samples kept at 60°C for 20 min. The slides were mounted with Vectamount permanent mounting 






Cells cultured on poly-D-lysine (Sigma-Aldrich)-coated chamber slides were fixed first with 4% 
paraformaldehyde for 30 min and then with ice-cold methanol for 30 min. Immunocytochemistry 
was performed using a MACH 1 Universal HRP–Polymer Detection kit (M1U539 G, Biocare 
Medical) for rabbit primary antibodies and Goat APPolymer Kit (GAP514 G, Biocare Medical) for 
goat primary antibodies, according to the manufacturer’s instructions. Betazoid DAB chromogen 
(BDB2004 H, Biocare Medical) and Warp Red™ chromogen (WR806 H, Biocare Medical) were 
used as chromogens. The cellswere counterstained with haematoxylin for 2 min. Anti-c-Kit, [KAP-
TK005 (Stressgen Bioreagents)] and anti-titin, SC-8724 (Santa Cruz Biotechnology) were used as 
primary antibodies. 
22. Statistical analysis 
All data are expressed as meanstandard deviation (SD). qRT–PCR data in the form of cycle 
thresholds (C) were exported to Microsoft Excel. The data were analysed as 2–ΔCT and 2–ΔΔCT 
compared to the level of the same mRNAs in the heart tissue. Value comparisons of the genes 
between treatments were calculated with one-way ANOVA with Bonferroni’s multiple comparison 
test. Values were considered significantly different at p<0.05. These analyses were performed using 




























1. Material characterization 
3D scaffolds Poly-lactic Acid-N and U with random porosity are prepared by dissolving the salt in 
order to obtain a useful combination of high compressive strength and uniform interconnected 
pores. The morphological and structural characteristics of the scaffolds produced by dissolution of 
salt depend on a number of variables including the concentration of P(d,l)LA, loading of solid 
particles of salt, particle size and use of the process aqueous. The distribution were                                        
observed in the porous structure with pore sizes in the range 150 and 224 µm (Figure 1 b-c).                                                                        
Silk porous structures with different morphologies were prepared using freeze-drying and 
electrospinning techniques (Figure 1d-f). To obtain porous sponges, a silk fibroin–water solution 
(5% w/v) was frozen under different conditions, thus affecting pore size and distribution. A 
relatively uniform pore morphology and distribution were observed in the porous structure obtained 
by freezing at –80 C (Figure 1d), with pore sizes in the range 28–85 mm. The scaffold produced by 
inducing a temperature gradient demonstrated a well-orientated sheet-like structure, with a bimodal 
pore size distribution in the range 200–400 mm (largest pores), as shown in Figure 1f. The 
electrospun net showed fibres that were randomly distributed in the mats, with an average fibre 
diameter of 33274nm (Figure 1e).The water up-take capability of the porous scaffolds was also 
evaluated. The scaffold with orientated lamellae showed higher water uptake (728%) compared to 




























2. Cardiac stem cell isolation and characterization 
 
Cardiac immature cells were isolated from adult rats using a differential adhesion method                   
(Figure 2). Two weeks after cell isolation, a good amount of proliferating cells was obtained. 
Isolated cells were characterized by flow cytofluorimetric analysis and, as shown in Figure 3a, the 
fraction of c-Kit positive cells varied from 61.0% to 96.7% (mean 83.23 ± SD 19.3) as previously 
described [101], Sca-1 positive cells varied from 74.6% to 98.2% (mean 86.93% ± 11.83), MDR-1 
positive cells varied from 61.1% to 72.3% (mean 63.13% ± 5.68). The expression of the three 
markers was also confirmed by immunofluorescence analysis (Figure 3b-d). 
 
Figure 1. SEM micrographs of BDTM Three Dimensional OPLA® Scaffold  150x (a), Poly-lactic Acid -N  and U random 
porosity Magnification = 52x (b-c). Silk fibroin scaffolds used in the in vitro and in vivo experiments: (d) scaffolds with 
random porosity (RP), magnification =  150x; (e) electrospun nets (F) magnifications = 5000x; (f) partially orientated 















In order to investigate the tumorigenic capacity of isolated cells, specific in vivo and in vitro tests 
were performed. 7-10 days after the beginning of the in vitro tumorigenicity test, Hep-2 (positive 
control) started to replicate producing multicellular agglomerates, while the negative cells (VERO) 
showed atrophy. Both the in vitro and in vivo test revealed that CSCs: There were no evidences of 
tumors in the several organs analyzed in mice inoculated with VERO and cardiac progenitor cells 
(Figure 4). Plates were kept in incubator at 37°C for 3 weeks: no clusters formation, negative test 
(Figure 5) 
 
Figure 2. Digestion tissue and cell preparation 
Figure 3. Cardiac progenitor cell characterization. 
Cytofluorimetric analysis to evaluate the percent of c-
Kit, Sca-1 and MDR-1 positivity (a). 
Immunofluorescence analysis to c-Kit (b), Sca-1 (c) 



















   
     
 
 






























      
 
Figure 5. Tumorigenicity Test in vitro. 
Figure 4. Histological analysis of organs after 
CSCs inoculation in mice. Organs of two 
different mice were analyzed (A-J and K-T). 




Cells selected with anti-Sca-1 antibody-coated magnetic beads showed the same expression levels 
of Sca-1, c-Kit and MDR-1 surface markers as non-selected cells. The surface markers CD73, 
CD14 and CD90 were tested by RT–PCR for each experiment to verify that there were no 
mesenchymal stem cells in the preparation, as previously described. These three markers were not 
expressed in our samples. Cells were seeded by capillarity in porous scaffolds and layered on 
electrospun nets. For porous scaffolds in P(d,l)LA and silk fibroin, a small drop of medium–
collagen–CSCs (600000 cells/20 ml) was added to two small dry pieces of the matrices (two 
samples with approximately the same drop volume). For electrospun nets, the same drop was put on 
the top of the sheet and layered with 150 ml collagen I diluted in M-199 medium (1:8). Both porous 
and electrospun nets were placed into BD inserts and covered with medium. This method insured a 




             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             





3. Cells in three-dimensional culture are partially differentiated in vitro: 
morphological evaluations 
 
In a previous study performed in our laboratory, scaffolds were used to study the differentiation 
potential of CSCs [97]. In order to understand which was the better condition for cell differentiation 
induction, three-dimensional cultures with BD OPLA scaffolds, customized P(d,l)LA and Silk 
fibroin scaffolds were performed. Morphologic features of CSC grown bi-dimensional culture are 
shown in Figure 7a; as displayed in the Figure 7b, cells were equally distributed inside the scaffolds 
and perfectly embedded in the scaffold matrix (Figure 7d). CSCs were let grow into the scaffolds 
Figure 6. Preparation of the insert in CSC, Collagen and biomaterial. 
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for 7, 14 and 21 days in their normal growing conditions ; as shown in Figure 7e-f after 21 days 
they expressed great amount of troponin T. A more accurate TEM observation showed the presence 
of caveolae on the cell membrane (Figure 7c). Since 3D cultures were performed embedding cells 
in collagen I, in order to understand whether cell differentiation was depending on the presence of 
the three-dimensional structure offered by scaffold or not, CSCs were cultured for 21 days in 3D 
matrix made by collagen I, without scaffolds. Fascinatingly, the cytoplasm appeared more granular 
and organized proposing a higher degree of differentiation (Figure 7d) 
 
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
       
In morphological analysis of semithin sections after 21 days, these cells grew inside the scaffold 
BD, P(d,l)LA and Silk fibroin scaffolds were uniformly distributed and synthesized a great quantity 
of ECM revealed that cells appeared huger and full with material similar to unorganized sarcomeres 
Figure 7. Phase contrast image of isolated cells in 2D cultures (a), ematoxilin/eosin staining of 
isolated cells cultured for 21 days inside BD OPLA scaffold (b). TEM image of the OPLA scaffold 
showing the cellular membrane, the cytoplasm and one caveola (c). E). Methylene blue stained 
semi-thin section of 21days 3D cultures inside collagen I (d). Confocal scanning microscopy 









or cytoskeletal proteins. They changed their morphology, adapt their cell growth to the internal 










            
             
             
          
 
 
                                                                                                                                                                                                          











4. Testing of biomaterials: In vivo reaction to biomaterials 
To investigate the possibility to use customized P(d,l)LA and fibroin scaffolds in cardiac tissue 
engineering, we tested the immunogenic properties of porous and partially oriented scaffolds 
prepared with different protocols, by injecting small pieces embedded in rat collagen I in the dorsal 
region of athymic Nude-Foxn1nu mice for 45 day. We used collagen I as the embedding medium, 
because cardiac stem cells showed a higher degree of cardiac differentiation in in vitro three-
dimensional cultures as previously described [97]. As shown in Figure 8, all scaffolds both 
P(d,l)LA and fibroin (Figure 8b-e), gave a FBR similar to the BD OPLA® scaffold (Figure 8a) 
previously used in our studies [97]. This FBR was characterized by the activation of macrophages 
with the formation of giant cells, neovascularization and encapsulation. No giant cells were visible 
on the surface of the F nets (Figure 8d).  
 
a 
Figure 6. Cardiac stem cells partially differentiate in vitro inside porous scaffolds and collagen gel. Morphological analysis of 3D 
in vitro cultures. BD OPLA, P(d,l)LA-U, P(d,l)LA-N, Silk fibroin F, RP and O.  
b
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5. Interleukin-mediated foreign body reaction 
The expression of CD11b, IL-4 and IL-13 was analyzed in immunofluorescence and confocal 
microscopy (Figure 8a-c), confirmed the presence of giant cells and the induction of a foreign body 
reaction when biomaterials alone were implanted. CD11b (Figure 9a), a surface marker of giant 
cells [171], was expressed on the surface of macrophages adhered to the chords of the porous 
P(d,l)LA and fibroin samples. IL-4 and IL-13 are two interleukins that are expressed during a 
foreign body reaction and induce the fusion of macrophages on the surface of the scaffolds. Our 
confocal analysis showed the expression of both interleukins in the presence of porous P(d,l)LA and 
fibroin samples (Figure 9b-c).  
 
 
6. Testing of biomaterials and CSC in vivo 
Figure 8. In vivo reaction to biomaterials: a morphological analysis. Small pieces (2 mm2) of biomaterials alone were implanted 
subcutaneously in Nude mice to evaluate the immune response. Masson’s trichrome staining of BD (a), P(d,l)LA-U (b), 
P(d,l)LA-N (c) RP (d), F (e), O (f). 
Figure 9. Foreign body reaction to biomaterials 
and CSCs. BD, RP and O scaffolds induced an IL-
4 /IL-13-mediated foreign body reaction with 
CD11b+ giant cells. One image per reaction is 
shown because the results were identical for all 
three mentioned scaffolds 







To understand the behavior of the immune system against CSC seeded within the scaffold was put 
in place a specific protocol where the construct with CSC, Medium and Collagen I was kept in 
culture within the same scaffold for a few days using medium M199 culture media supplemented 
with 20% FBS and then inoculated in three different animal models.  
Haematoxylin/eosin stained sections of BD OPLA scaffold (A), porous P(d,l)LA-N scaffold (Figure 
10b), porous P(d,l)LA-U (Figure 10c), scaffold silk fibroin porous scaffold RP (Figure 10d), silk 
fibroin porous partially oriented scaffold O (Figure 10e), silk fibroin partially oriented nets  F 
(Figure 10f) show a foreign body reaction and the presence of giant cells is evident.  After a 45-day 
incubation in vivo, the implanted silk fibroin scaffolds did not appear to have undergone any 
substantial biodegradation (Figure 10d-f). 
Scaffold F shows a different behavior than porous scaffolds Although the material is compact and 
difficult to deliver in the subcutaneous region, after 45 days, there was only a light capsule and 
macrophages were not visible. Also fibroblasts colonized the surface of the net, but not seem to be 























d e f 
Figure 10. Testing of biomaterials and CSC in vivo. Histological analysis of skin biopsies of athymic Nude-Foxn1nu mice for 
45 day. Haematoxylin/eosin stained sections: BD OPLA scaffold (a), porous P(d,l)LA-N scaffold (b), porous P(d,l)LA-U (c), 
scaffold silk fibroin porous scaffold RP (d), silk fibroin porous partially oriented scaffold O (e), silk fibroin partially oriented 
nets F (f). 
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Sections counterstained with hematoxylin/eosin in nude rats (Figure 11a, b) and SCID mice 
(Figure11c, d) confirmed the presence of a strong degradative action against the scaffolds with 
random porosity in P (d, l) LA (Figure 11a, c) unlike the silk fibroin scaffolds (Figure11b, d) where 
we note the presence of a dense cellular infiltrate. Porous scaffolds induced the same foreign body 
reaction with encapsulation, dermal fibroblast invasion and giant cell formation subcutaneously in 
SCID mice and Nude rats. 
  
 
             
             
             







7. Characterization of the immune response to the CSC in vivo: fate of rat cells 
after implantation 
 
When CSCs were injected in the subcutanous region of Nude mice, as cells and collagen constructs 
(Cell+coll), they induced a nodule formation and T-cell mediated immune response (Figure 12a-d). 
The results were the same at 21 and 45 days. Samples underwent encapsulation (Figure 12a, c). 
Collagen residues were still visible in the center of the encapsulated area (Figure 12a, black arrow). 
Masson’s trichrome staining showing the massive presence of lymphocytes (Figure 12c). and IL-4, 
an inflammatory cytokine, was detected inside nodules (Figure 12f)  
Immunohistochemistry with the anti-CD3 antibody confirmed this hypothesis and revealed that a 
subpopulation of T lymphocytes was still active in Nude mice, as previously reported (Figure12d). 
When CSCs were implanted in the same manner in Nude rats we note the same behavior  with T-
cell mediated immune response (Figure 12f). 
FISH provided a reliable method for characterizing the fate of the implanted Cell+coll (Figure 12h-
i) and Biomaterial+CSC (Figure 12g) constructs. The mouse centromere probe reveals the presence 
of mouse cells, while the rat cells are unstained. After 21 and 45 days only cells positive to the 
Figure 11. Testing of biomaterials and CSC in vivo. 
Haematoxylin/eosin stained sections of skin biopsies 
of athymic Nude-Foxn1nu rats in P(d,l)LA scaffold (a) 
and  silk fibroin (b). SCID mice in P(d,l)LA scaffold 





FISH probe were present, while rat donor cells were not detected in both conditions (Fig. 1G). Rat 























8. Extracellular matrix molecules expression in bi-dimensional and 
threedimensional cultures 
To evaluate the differentiation state and the level of expression of mRNAs encoding ECM 
molecules, adhesion proteins, eNos pathway members, and structural proteins typically expressed in 
cardiomyocytes, we performed several RT-PCR reactions in CSCs cultured in bi and three-
dimensional cultures and cardiac tissue. The expression of extracellular matrix proteins and their 
receptors is essential for the proper development and for keeping myocardium functional.                                       
As shown in Table 3, cells cultured for 21 days in commercial OPLA scaffolds show a low 
expression pattern of almost all considered genes compared with the expression pattern of cells 
10 µm 
200 µm 20 µm 
20 µm 
Figure 12. Fate of rat cells after implantation. (a-b), Haematoxylin/eosin staining of CSC and collagen I constructs after 45 days 
from implantation into Nude mice. (c), Masson’s trichrome staining CSC and collagen I constructs after 45 days from 
implantation into Nude mice.( d), CD3 immunostaining of the subcutaneous biopsy.(e), IL-4 immunostaining of the subcutaneous 
biopsy. Masson’s trichrome staining of CSC and collagen I. (f) after 45 days from implantation into Nude rats.(g), FISH analysis 
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cultured in customized P(d,l)LA scaffolds. On the other hand, although cells in three-dimensional 
scaffolds have been cultured in presence of collagen I while CSCs cultured in collagen I alone 
expressed many proteins at a level similar to the cardiac tissue. Particularly, extracellular matrix 
proteins like laminin and fibronectin are more expressed in 3D-culture with collagen I compared to 
3D-cultures with commercial and customized scaffold and 2D-cultures; the same happens in the 
case of almost all the ECM receptors and downstream signaling molecules as integrin classes, AKT, 
ILK and FAK. CSCs cultured in flasks expressed mainly fibronectin, calmodulin and heat shock 
protein 90 (HSP90). As shown in Table 1, CSCs cultured inside the different scaffolds expressed 
several mRNAs, but the O sample expressed the most mRNAs compared to the other constructs in 
particular integrin α7β1 provides a mechanical link between muscle fibres and the basement 
membrane in skeletal muscle, contributing to costamere assembly and eNos known to be implicated 
in signal transduction mechanisms affecting myocardial contractility [169]. Samples with many 
positive signals are most likely the most differentiated ones. 
 
             
             


















In vivo In vitro Scaffold Control CSC and Scaffold Natural CSC and Scaffold Natural 
Table 3. Expression of ECM molecules and receptor, cardiac-specific genes by RT-PCR 
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9. Expression of sarcomeric proteins 
To understand the degree of differentiation in the different constructs, we analysed the gene 
expression of ten known rat sarcomeric proteins comparing bi-dimensional (2D) samples and/or 
heart tissue to Cell+coll, BD OPLA (BD, our control), random porosity (RP) and partially oriented 
(O) fibroin porous matrices, fibroin electrospun nets (F), P(d,l)LA-U and P(d,l)LA-N with random 
porosity (Fig. 4). 
The data were analyzed as 2-ΔCt (Table 4) and 2-ΔΔCt (Table 5). With respect to 2-ΔCt, only cardiac α-
actinin 1 was considerably expressed in the 2D and P(d,l)LA samples. When BD and P(d,l)LA were 
the scaffold, the lower expression of all ten mRNAs was observed. Silk fibroin scaffolds induced 
good expression of all the mRNAs, Cell+coll and Sample O expressed higher levels of titin  and 
muscle Z-line capping protein. Cell+coll and Scaffold F show higher levels Cardiac Troponin T 
type 2. Telethonin-like mRNA was expressed only by O. Cardiac troponin I type 3 was expressed 
only by silk fibroin sponges. Among the synthesized scaffold, the sample O showing the expression 
of all the genes analysed probably due to the mechanical properties of the scaffold that is capable of 
driving the differentiation process. 
For the 2-ΔΔCt method, in Table 5, only muscle Z-line capping protein, myosin-binding protein H, 
and titin showed a level of expression comparable to the heart tissue sample. Among these three 
mRNAs, titin was well expressed in silk fibroin scaffolds and Cell+coll constructs (Fig. 4b). 









10. Expression of Titin and characterization of Z bodies  
Real-time PCR data are confirmed by the expression of titin in Cell+coll, RP, O and F, we 
performed immunohistochemistry on TEM–EPON embedded samples. As Figure 6 shows, titin was 
not expressed in 2D samples (Figure 13a) compared to c-Kit (our positive control) (Figure 13b), 
while it was expressed in Cell+coll (Figure 13d), RP (Figure 13f), O (Figure 13g-i) and F (Figure 
13h) in 21-day samples. Negative controls of 2d and Cell+coll samples are shown in Figure 13c and 
e. EPON embedded constructs have been created in parallel with Real-time PCR samples. The 
choice of silk fibroin samples and Cell+coll is due to expression levels higher in real-time PCR 
analysis highlighted respect to P(d,l)LA samples. In the samples Cell+coll and scaffold O where 
titin was expressed, dense bodies with aligned fibres (forming Z-bodies) were visible inside the 
cytoplasm of the cells. In 21-day samples (Figure 14b), forming Z bodies with aligned and similar 
thick fibres were visible in 21 day O and Cell+coll samples; while in 72 h samples (Figure 14a) 
only disorganized fibres were noted both samples. 
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Figure13. Immunohistochemistry showing titin expression in CSCs 
and scaffold samples. The first row shows the expression of titin (c) in 
2D-cultured CSCs compared to the negative control (a) and our 
positive control c-Kit (b). The other pictures show the expression of 
titin in EPON 1mm semi-thin sections: (d) Cell+coll, negative control 
without the primary antibody; (e) Cell+coll; (f) RP; (g, i) O; (h) F 
samples.. Sc, scaffold; E, extracellular matrix synthesized by the same 
CSCs. Black arrows, titin-negative cells in the F sample [111]. 
Figure14. TEM image of disorganized fibres in 72 h Cell+coll samples. (b) TEM image of 
forming Z-bodies in 21 day Cell+coll samples. Fibres similar to (a) and (b) were also visible in 










The old dogma of a heart post-mitotic with myocytes formed during embryonic and fetal cardiac 
development and they responsible for the preservation of myocardial performance in the young, 
adult, old, and senescent heart has profoundly conditioned basic and clinical research in cardiology 
for the last three decades [68, 51]. Based on this paradigm, cardiomyocytes undergo during their 
vital cycle cellular to hypertrophy, cannot be replaced by the entry into the cell cycle of a 
subpopulation of nonterminally differentiated myocytes or by the activation of a pool of primitive 
cells that become committed to the myocyte lineage. However, the important work done from many 
researches in this field, introduce a highly dynamic perspective of the heart, where it is been 
possible the identification and characterization of a resident pool of stem cells that can generate 
myocite, and ECs and SMCs organized in coronary vessels [72]. This discovery has created a new, 
heated debate concerning the implementation of adult cardiac stem cells in the treatment of heart 
failure of ischemic and nonischemic origin. As described, the first experiment in which CSC were 
isolated from rat hearts 9 years ago by Anversa et al., using, as a marker, the Stem Cell Factor 
Receptor, c-Kit [72]. Few years later, the same marker resulted to be effective in isolating CSC also 
from human hearts [170]. The therapeutic effectiveness demonstrated by both human CSC in 
preclinical models of cardiac damage [170, 171], have given the start to the phase I clinical trials 
whose preliminary and promising results have been recently published [109,110]. With the current 
knowledge, to get a myocardial tissue in vitro from progenitor or stem cells it is considered as a 
hope for the future, currently the only chance of recovery of cardiac function in damaged heart is 
the transplantation of heart, but very often this opportunity is precluded by the lack of organ donors.  
The use of cardiac stem cells to repair a damaged myocardium, it is vital to find a surgical protocol 
that reduces the number of cells used, which maximizes the efficiency of the differentiation process 
and can be easily applied by surgeons. Effective treatment of heart failure is the  regenerative 
cardiology, where the conceptual framework regarding this protocol is simple, indeed stem cells 
could be used in the synthesis of new myocardial tissue lost as a result of disease[172]. There are 
important barriers that need to be investigated such as the number of cells that needs to be replaced 
and the loss of cardiomyocytes, that is accompanied by the formation of a fibrous scar, resulting in 
decreased pumping capacity of the heart. In a typical myocardial infarct it is estimated that one 
billion cardiomyocytes are lost. However, so far no study has been able to find an appropriate 
protocol to demonstrate an equal repopulation with transdifferentiated cardiomyocytes after cell 
therapy. Experimental studies have noted such as transferred cells are destroyed in large part from 
the heart between the first 24 to 48 hours after intracoronary infusion [173]. Indeed, in work 




Owing to the complexity and physiological requirements of functional myocardial tissue, an 
abundant source of cardiac myocytes alone is not enough to build a clinically useful graft. To 
enhance the pumping capacity of the failing heart, the cells able to remain in the heart after 
transplantation and survive, integrating into the native cardiac tissue. How individual differentiated 
cells come together to form a three-dimensional structure where the cardiomyocytes are 
subsequently coupled to each other in an end-to-end fashion by intercalated discs. These specialized 
structures, containing gap junction proteins that facilitate the spreading of the electrical impulse 
from one fiber of cardiomyocytes to another. Thus, the distinct cellular architecture of contractile 
tissue permits two key features of the physiology of the ventricular myocardium: rapid and 
coordinated spreading of the electrical impulse controlling the frequency of the heartbeat, and a 
coordinated contraction allowing the blood pumping to the tissues of the organism. Indeed, to 
improve cardiac function, transplanted cells must reach the correct structure with the myocardium 
of the host in specific way. How this organization is orchestrated isn't completely known, but 
published transplantation experiments show that integration does occur, raising the probability that 
ECM or resident cells in adult heart provide directional organization. As discussed above, the tissue 
engineering with grafts in myocardium with surgical implantation can prove an alternative option 
differently to injection of single cell suspensions into the damaged myocardium. Given the great 
importance of cardiac area it may prove fruitful to develop tissues structures able to integrate in 
anatomic damaged site. The greatest challenge in tissue engineering is provide an adequate supply 
of oxygen and nutrients. One approach has been to engineer thin cardiac sheets, which can then be 
stacked for in vivo delivery [174]. Although these layered sheets indicated some degree of 
electromechanical coordination and neovascularization in vivo, it isn't no clear if this approach can 
be optimized to yield full-thickness myocardium with an adequate blood supply. The addition of 
non-myocyte cellular components, such as fibroblasts and endothelial cells, leads to the formation 
of primitive vascular structures within engineered grafts, but the electromechanical properties are 
been seen not sufficient for normal functionality[175]. The scaffolds can be the alternative for 
increase the efficiency  because a fewer cells are needed contrary to injected cells directly in the 
myocardial tissue that are showed  dispersed and regeneration is very poor. The use of biomaterial 
may reduce the risk of thrombi indeed the construct could be fixed in the damaged area with 
specifics chirurgical sutures. It is been indicated such as the complete differentiation of CSCs with 
formation of myofibrils organized is very difficult, few groups of research have had succeed in the 
differentiation in vitro, where the integration of these cells into the damaged myocardium is been 
suggested such as an artefact due an effect of fusion of cells that are already present in vivo, instead 
of a real regeneration of the myocardium. Experiments of co-colture showed the complete 
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differentiation of CSCs, with the formation of organized sarcomeres reached coupled to a feeding 
layer of neonatal cardiomyocytes, as previously demonstrated. It has also been suggested that the 
particular architecture of a scaffold can be able to drive the structural cardiac organization , where 
the concomitant effect of soluble factors, cell–cell interaction signals and 3D structure can be 
determinate for complete differentiation [176]. When we proceed to use biomaterials to deliver stem 
cells to the site of implantation, it is opportune think to possible reactions of the immune system 
and the possible foreign body reaction (FBR). This phenomenon also known as the host response to 
implanted biomaterials, involves a complex cascade of immune modulators, including various cell 
types, soluble mediators, and cellular interactions [159]. The FBR is considered disastrous for 
patients, also if in other cases it is been studied from another point of view such as initial 
inflammation whence it starts a phase of tissue regeneration. The two major problems with FBR are 
a fibrotic capsule and the promotion of catabolic enzymes and reactive intermediates, with the 
activation from the systemic circulation of macrophages and giant cells, which derive from the 
fusion of macrophages. The presence of giant cells is driven by the release of interleukin-4 (IL-4) 
and IL-13 in the site of inflammation. Lymphocytes transiently appear at the implant site during the 
inflammatory response but the lymphocyte response to biomaterials is still unclear [162]. 
Lymphocytes have been shown to influence macrophage behavior at biomaterial surfaces in vitro 
through enhancement of monocyte/macrophage adhesion, macrophage fusion, and macrophage 
activation.2,3 These effects are mediated by indirect and direct lymphocyte interactions with 
monocytes, macrophages, and foreign body giant cells. In study of Chang et al., they demonstrate 
that CD4+ and CD8+ T lymphocytes were the predominant lymphocyte subtypes adhering to 
biomaterial surfaces and to macrophages and foreign body giant cells. The reduced of CD56+ NK 
cells on the biomaterial surfaces does not rule out the fact that NK cells may be interacting at the 
surface. Other studies have shown a predilection for CD3+ T lymphocytes to adhere onto surfaces 
pre-adsorbed with particular extracellular matrix proteins. The differences about the composition of 
scaffolds surfaces utilized has demonstrated such as the biomaterial is important for the percentage 
of CD4+ and CD8+ T lymphocytes that interact with adherent macrophages and foreign body giant 
cells. for all these reasons in the present study we focused on the induction of myogenic 
differentiation of adult cscs in vitro using biosynthetic and natural biomaterials such as the poly-
lactic acid and the silk fibroin, in porous matrices and an electrospun net. Another important studied 
aspect, is the mechanisms that regulate the immunological behaviour of rat CSC and their fate after 
injection in animal models of nude mice, nude rats and SCID mice [163].                               
Cardiac stem cells from adult rat myocardium were isolated and after 10 days characterized for the 
expression of some stem cell markers on the cell membrane. Flow cytometric analysis revealed 
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such as these cells are largely positive for all the three considered markers: c-Kit, Sca-1 and MDR-
1. The isolated cells did not induce cancer or masses in the several organs analysed and did not 
induce colony forming units even in vitro. These c-Kit+ CPCs are able to grow inside a 
commercially available poly-lactic acid scaffold (BD OPLA) and may synthesise cardiac proteins, 
such as cardiac troponin T [97]. As observed by transmission electron microscopy, these cells had a 
cytoplasm that engulfed with proteins even though the plasma membrane was still intact. In order to 
stimulate CSC differentiation, three-dimensional cultures in P(d,l)LA and silk fibroin porous 
scaffolds, electrospun net and collagen I matrix alone were performed. Morphological analysis of 
CSCs in 3D cultures showed a higher state of differentiation of CSCs in 3D cultures compared with 
2D cultures; particularly, cytoplasm of CSCs grown in a collagen I matrix seemed to be more 
granular than cytoplasm of CSCs grown in P(d,l)LA, silk fibroin or BD scaffolds. Since 3D cultures 
in P(d,l)LA and silk fibroin scaffolds were prepared first embedding cells in collagen I, this 
evidence let us suppose that collagen I itself is responsible of differentiation. To investigate the 
possibility of a possible FBR to customized P(d,l)LA and fibroin scaffolds in cardiac tissue 
engineering, we tested porous and partially oriented scaffolds prepared with different protocols, by 
injecting small pieces embedded in rat collagen I in the dorsal region of athymic Nude-Foxn1nu 
mice, we used collagen I as the embedding medium [97]. A FBR is common for poly-lactic acid 
biomaterials used in orthopedic surgery, we show  in our study that this reaction is undesired, 
because it could have a negative effect about our stem cells significantly, influencing the initiation 
of any differentiation process. Fibroin scaffolds derives from the silk, used to obtain structures 
tolerated by the host immune system with an implant able to mechanically to rule the hydrodynamic 
environment, critical to support cell growth in vitro and especially in vivo [177]. In our study only 
fibroin partially oriented fibres (sample F) did not induced a FBR. In partially oriented nets, cells 
from the dermis colonized the scaffold without entering the structure itself, because the spaces 
between fibres are of nanometric size. Only fibroblasts colonized the surface of the scaffold, and 
there were neither fibrous capsule nor neovascularization.                      
Both P(d,l)LA and silk fibroin porous scaffolds synthesized gave a FBR, characterized by giant 
cells, a fibrous capsule and neovascularization. The material preparation common to P(d,l)LA three-
dimensional scaffolds is the salt leaching method. Probably this method may create an 
immunogenic film over the surface of the scaffold. A FBR for fibroin scaffolds has been reported 
only once by Dal Pra and colleagues [178], where they studied the immunogenicity of disorganized 
degummed fibroin fibres, reporting a mild FBR. When the scaffolds were implanted inside the nude 
mice, a foreign body reaction with CD11b+, giant cell formation, and IL-4 and IL-13 release seem 
to prevail in P(d,l)LA scaffold. The first experiment about the FBR induced in nude mice, it show 
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that silk fibroin is a possible biodegradable non-immunogenic biomaterial which can be used to 
deliver our cardiac stem cells to the site of injection not activating a violent inflammatory reaction. 
In the present study, we provide the first description of an adverse immune response activated by 
the adult CSC isolated and inoculated in Nude-Foxn1nu mice, athymic Nude-Foxn1nu rats and SCID 
mice for 45 where the presence of macrophages and giant cells is high. The fish experiment with 
CSC and biomaterial and only CSC only  embedded in rat collagen, show as the cells are destroyed 
during this inflammation process, both in Nude mice and rats. Even in athymic models animal, a 
peripheral subpopulation of positive T-cell for CD3 it is indicated to create a massive infiltrate in 
the site of injection with the induce IL-4 synthesis and the complete destruction of injected adult 
CSC. These cells generate a T-cell-mediated immune response that is similar to that induced by 
HLA bearing cells [179]. Although it has been shown that the memory component of the adaptive 
immune response is not present in the FBR,[180] it is been showed as the presence of T and B 
lymphocytes at the implant site has a role for these cells.6 Indeed, Th2-polarized T cells were 
originally theorized to be the source of the cytokines IL-10, IL-4, and IL-13 during the FBR [181]. 
However, a recent report demonstrated that T-cell-deficient mice were still able to develop a  FBR 
and that the levels of IL-13 and IL-4 were not affected by the T-cell deficiency [180].It has been 
demonstrated in vitro that lymphocytes that activated the development of foreign body giant cells 
through both indirect and direct cell-cell interactions [163]. Molecular analysis of the expression 
pattern of ECM coding genes, ECM receptors, downstream signaling molecules and cardiac specific 
genes confirmed this hypothesis. Comparison between the expression pattern of cells grown in  bi-
dimensional culture and in 3D BD, P(d,l)LA and silk fibroin scaffolds, cells in collagen I 3D-matrix 
revealed that genes encoding for ECM molecules, integrins, cardiac-specific proteins were more 
expressed in presence of collagen I only and inside partially orientated porous scaffolds (O). In 
particular, they expressed high levels of integrin subunits α7 and β1, specific for laminin, which is 
one of the main constituents of the cardiac ECM [182]. Moreover, it is known that integrin a7b1 
provides a mechanical link between muscle fibres and the basement membrane in skeletal muscle, 
contributing to costamere assembly[183]. Upon maturation of myofibers, the α7β1 integrin is 
localized along the sarcolemma and it is concentrated at costameres [184]. The integrin is important 
to maintaining stable connections at these specialized sites of contact between myofibers and the 
extracellular matrix that are needed to receive and transmit signals and withstand contractile forces. 
The α7β1 integrin also functions in signal transduction as a mechanoreceptor, and it protects muscle 
against exercise-induced damage [185]. Thus, the α7β1integrin is essential for maintaining muscle 
integrity and stabilizing connections between the sarcolemma and extracellular matrix. The 
importance of β1 integrin expression in cardiac cell cycle has been demonstrated using a 
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monoclonal β1-blocking antibody, which inhibits cell cycle progression in fetal but not neonatal 
cells [186]. In cardiomyocytes, the effects on the cell cycle may be related to the change in the β1 
isoform from A to D during the fetal to neonatal transition. The switch in integrin isoforms results 
from alternative processing of the cytoplasmic domain, and has been correlated with terminal 
differentiation in skeletal muscle cells [187]. Another β1 cytoplasmic domain variant, β1C, also has 
been shown to inhibit DNA synthesis and block cell cycle progression near the G1/S boundary. In 
cardiac muscle, little information is available on the expression pattern of integrins during the 
transition from active cell proliferation to terminal differentiation. Brancaccio et al. [188] studied 
changes in the cytoplasmic spliced variants of β1 integrin by immunostaining. Both β1A and β1D 
were present in fetal mouse cardiomyocytes, but in adult cardiomyocytes only the β1D isoform 
could be demonstrated. Inactivation of integrin β1A and β1D subunits in knockin/knockout studies 
has been shown to mildly affect cardiac morphology but provided no information related to effects 
on the cell cycle.  The work of Maitra et al. [189]defines the pattern of β1 and α integrin isoforms in 
developing rat primary cardiomyocytes and correlating the changes to the expression with cell cycle 
exit. As a consequence of the switch in β1 isoforms from A to D, there is a change in the associated 
α partners. Immunoprecipitation with β1 antibody from heart extracts showed that the β1-subunit is 
associated with α3, α5, α7B, and αV monomers [187]. When immunoprecipitation was carried out 
with an antibody specific for β1D, however, the β1 isoform was only associated with α7B [187].  
The eNos gene expression is evaluated in O sample only, this result is important because eNos 
generate of NO and it is activated by various physiological mediators, including mechanical shear 
stress [190], estrogens [191], insulin [192], acetylcholine, and other receptor-dependent agonist. 
The expression pattern sarcomeric proteins is bene analyzed in all 3D cultures analysed, and when 
comparing the real-time data with the expression levels in the cardiac tissue, only muscle Z-line 
capping protein (CapZ) and titin were expressed at considerable levels in both the Cell+coll and O 
samples. The presence of assembled Z-bodies of nascent premyofibrils support our hypothesis that 
c-Kit+ CSCs 3D cultured in a collagen I gel, with or without scaffold, they are able to 
differentiation in cardiac cell. Differences in the values of titin levels among samples probably 
depended on both the levels of the mRNA in the single cell and the number of titin-expressing cells 
in the sample. The z-discs (z-lines, z-bands) are the lateral boundaries of the basal contractile unit of 
the myocyte, the sarcomere. Three of the four filament systems of the sarcomere, filamentous F-
actin, titin, and nebulin/nebulette, interact with Z-disc structures. the function of the z-disc is in 
relation its position able to sense, integrate, and transduce biomechanical stress signals [193]. The 
z-disc is structurally linked to the sarcolemma via the costameres, which circumferentially surround 
the z-disc. Both CapZ and titin are involved in the cardiac Z-disc signalling network. CapZ is the 
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capping molecule found on the barbed ends of F-actin filaments in the sarcomere at the Z-line. It 
interacts with α-actinin and regulates actin dynamics [193]. The cardiac sarcomere contains, in 
addition to actin-based thin filaments and myosin-based thick filaments, the giant protein titin (also 
called connectin). While the proteins that compose the thin and thick filaments are responsible for 
generating active force in the sarcomere, titin provides passive elasticity to muscle. This elastic 
property of titin, in addition to the extracellular matrix, defines the passive stiffness of muscle that 
resists sarcomere stretch. A single titin molecule spans the half sarcomere, binding to the Z-disk and 
to the thin filament at its N-terminus, and binding to the thick filament and M-band towards its C-
terminus. Between thin and thick filament, binding domains of titin acting as a molecular spring 
that extends during sarcomere stretch[194]. This study demonstrates such as physicochemical 
stimuli, provided by 3D structure of biomaterial, in particular, about the behaviour showed by 
partially orientated fibroin scaffolds and biological stimuli provided by the collagen gel and by the 
propensity to produce ECM that cells autonomously synthesize, it is been noted that adult CSC are 
able  differentiate to cardiac function, that properly combined in vitro to resemble the stem cell 
niche rules CSC commitment. Moreover, the obtained data about fibroin orientated scaffolds and 
collagen gels may help overcome the issues concerning cell dispersion obtained when stem cells are 
directly injected in the damaged myocardial area. Future investigations of the full spectrum of genes 
involved in sarcomeric formation and how these functionally genes interact, could improve the 
understanding of their role in the CSC biology also the pathways underlying to the averse immune 
reaction is relevant for the production of new biomaterial able to provide the correct 3D structure 
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